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This research investigated the repercussions of aberrant PAX3 re
expression in cutaneous malignant melanoma (CMM). The transcription
factor encoded by PAX3 is amongst the first expressed in the embryo, with
a principal role in the development of the melanocytic lineage. We theorised
that abnormal re-expression of FAX3, consistently observed in CMM as
compared to normal melanocytes, is linked to progression of CMM.
Previous studies have stated that expression profiles of PAX3 in CMM
demonstrate predominant generation of a protein encoded by exons 1-9

(PAX3D) utilising cryptic splice sites in post-transcriptional pre-mRNA
splicing. By contrast, normal human skin demonstrates low level generation
of PAX3C (encoded by exons 1-8). Using RT-PCR based techniques and
immunohistochemistry, we present original evidence of Pax3c, Pax3d
mRNA and protein expression in normal murine embryogenesis and
melanogenesis, identifying a conserved role for the Pax3d protein in
transcriptional regulation of the murine melanoblast. Furthermore, to
identify a role for Pax3 in adult skin, we used a reliable time-scale for the
strict coupling of melanogenesis to active hair regrowth; Pax3c and Pax3d
expression profiles were assessed during depilation experiments which
induced murine melanocytic stem cells to proliferate, migrate into the hair
cortex and differentiate in order to produce melanin for new hair. Results
indicate that strict temporal expression of Pax3d may be linked to either
melanoblast proliferation or migration in early melanogenesis thus
supporting a possible role for PAX3D in the tumourigenesis of CMM.
Differences in the structure of the C-terminal region of the
transcription factors P AX3C and PAX3D influence transcriptional
activation of downstream target genes via protein-protein interactions. As
PAX3 is known to up-regulate the gene encoding micropthalmia-associated
transcription factor (MITF), we sought to establish a possible link between
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aberrant PAX3 expression and regulation of MITF in CMM by comparison
of Pax3c, Pax3d and Miif-m mRNA expression in murine embryogenesis and
melanogenesis. Results indicate that while Miif-m expression may be reliant
on Pax3c expression, Pax3c expression is not solely linked to Miif-m
upregulation. Moreover, no apparent correlation appears between Miif-m
and Pax3d expression as random inverse and overlapping expression of
these genes was observed during murine embryogenesis and adult hair
regrowth. Finally, a link between Pax3 and c-Kit was sought. Knowing that
loss of the c-Kit tyrosine kinase receptor occurs in CMM and that PAX3
functions as a gene repressor, we analysed mRNA profiles of Pax3c, Pax3d
and c-Kit in depilation experiments to investigate possible inverse
correlations in gene expression. Although the c-Kit promotor sequence
reveals potential binding sites for Pax3, our results indicate that loss of c-KIT
expression in CMM is not potentially linked to aberrant PAX3 expression.
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DEFINITION OF ABBREVIATIONS --------Table 1. Terms and abbreviations.

Terminology

Definition

PAX3

Gene encoding the human transcription factor PAX3

PAX3

Human PAX3 transcription factor

Pax3

Gene encoding the murine transcription factor Pax3

Pax3

Murine Pax3 transcription factor

CMM

Cutaneous malignant melanoma

MITF-M

Gene encoding

human micropthalmia-associated

transcription factor (melanocyte specific)
Mitf-m

Murine micropthalmia-associated transcription factor
(melanocyte specific)

Miif-m

Gene encoding murine Mitf-m

SCF

Stem cell growth factor

c-KIT

Human receptor tyrosine kinase for SCF

c-I<.it

Murine receptor tyrosine kinase for SCF

c-KIT

Gene encoding human c-KIT

c-Kit

Gene encoding murine c-Kit
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1

INTRODUCTION

1.1 INTRODUCTIO,�---------------As far back as 1910, cancer was suspected to be primarily a genetic
disease; undeniably, the past century has witnessed the unravelling of
numerous genetic events involved in the pathogenesis of the neoplastic cell.
The basis of this research lies in the supposition that gene transcription
factors that function to regulate development within the embryo are often re
expressed in tumourigenesis and therefore able to be selectively utilised by
neoplastic cells for cancer progression. In line with this supposition, CMM
arises within cells of neural crest origin, a lineage in which PAXJ is a principal
regulator of progenitor cell migration and differentiation. This, combined with
the observation that PAXJ is over-expressed in CMM (in contrast to virtually
no expression in normal skin or benign naevi) led to the hypothesis that the
developmental role of PAXJ may be re-activated in CMM and thus contribute
to neoplastic progression of melanocytes. The aims of this research therefore
became to investigate normal Pax3 expression profiles during key stages of
melanocytic development in order to more clearly hypothesise possible
repercussions of aberrant re-expression in CMM. Correlations were sought
between Pax] expression and the expression of c-Ki,t or Miif, two potential
downstream targets of Pax3 to examine the consequences of aberrant PAXJ
expression in CMM.

2

2

LITERATURE
REVIEW
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"Science increases our power in proportion to the diminishing ofour pride ,,
Claude Bemard

In an effort to understand the implications of increased PAX3
expression in CMM, this literature review focuses on development of
melanocytic cells from the neural crest, melanocytic function following
differentiation and pigment production, aetiologies and pathogenesis of
CMM, PAX3/Pax3 involvement in embryogenesis and finally, key proteins
thought to be activated by PAX3 and implicated in the progression of CMM.
The scope of the review is wide-ranging; it has led to a publication (Blake &
Ziman, 2003) which generated international interest and formed the
foundation on which the discussion is based.

2.1 MELANOCYTIC CELLS------------Melanocytes are specialised pigment producing cells located primarily in
the epidermis, hair follicle, cochlea and choroid of the eyes. Production of
melanin pigment within each subpopulation of melanocyte is associated with
varying function according to the tissue. For example, in the stria vascularis
(the lateral wall of the cochlear duct), melanin pigment is thought to play a
role in hearing (Mou et al, 1997; Takeuchi & Ando, 1997; Masuda et al, 1994)
while in the choroid of the eye, melanin is essential for the maintenance of
vision (Hu et al, 2002). This review, however, focuses on epidermal
(cutaneous) and hair follicle (follicular) melanocytic cells, from their
specifications as melanoblasts (melanocytic stem cell) to their differentiation
into melanocytes (cells capable of melanin production). In order to unravel
possible repercussions of the aberrant expression of PAX3 in CMM, review
of the literature initially focused on the normal development of melanocytes.

2.1.1. Melanocytic Development
Due to lack of human embryonic tissues or models for study of
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melanocytic development, much of what is known about the migration and
differentiation of melanocytic cells has been studied in a murine animal
model. Throughout the review, reference will be made to melanocytic
development in mice, although it differs slightly from human melanocyte
development. Where necessary, key differences are noted.
In mice, neural crest cells become committed to the melanoblast
lineage at around embryonic day 8.5 (E8.5) and begin migration dorsolaterally
toward the ventral midline and into the dermis at around day E10.5 (Mayer,
1973). An early study by Mintz (1967), used

groups

of coloured mice,

containing two alternatively pigmented melanocytic genotypes to reveal that all
melanocytes in murine coats are clonally derived from a fixed, small number
of primordial melanoblasts that proliferate and migrate to prospective regions
of the dermis in a specific pattern, as described by Mintz:
"The animals are dramatically striped, with a series of broad transverse
bands of alternating colors extending down the full length of head, body,
and tail. The sharp mid-dorsal separation indicates that the two sides are
established autonomously, without physical contiguity, so that a left and
a right member are actually present. Each cell appears to proliferate
laterally, and to a lesser extent longitudinally, to fill the available space
between epidermis and dermis, bounded on each side by neighboring
clones. There are 17 successive bands down each side of an animal. The
head has three per side. On each side, there are 6 bands on the body, and
8 on the tail. The simplest explanation for these bands, consistent with
all known facts of pigmentary ontogeny, is that each is a clone of
melanoblasts, descended mitotically from a single cell." (Mintz, 1967)

That melanocytes of the murme coat are descended from a small
number of primordial melanoblasts whose progeny proliferate, migrate and
regionalise within specific regions of the body, may be analogous to human
melanocytic proliferation and migration; this will be further discussed in
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relation to germline pathogenesis of human melanocytes such as is seen m
giant congenital naevus (see page 29).
Following regionalisation of melanoblasts in the murine dermis, during
a specific window of time at around E12.5-13.5, melanoblasts enter the
epidermis synchronously and proliferate extensively (Yoshida et al., 1996).
Subsequently, at around E15, a subpopulation migrates toward the developing
hair germ (Hirobe, 1984). Here, a fraction of melanoblasts remain within the
follicle as stem cells, while others begin to terminally differentiate at around
E14, with pigmentation induced around 2 days later (Hirobe, 1984). After
birth, most epidermal melanocytes, except those of hairless areas such as the
ears and tail, undergo apoptosis (Hirobe, 1984) leaving only melanoblasts and
melanocytes of the hair follicles to produce pigmentation of the coat in mice.
In human melanocytic development, melanoblasts are found in the
epidermis at 9-1 1 weeks of gestation, prior to the development of the hair
germs (Hashimoto, 1991). Most of the primary hair germs over the skin
surface develop at around four months of gestation (Hashimoto, 1970). At
this point, a subpopulation of epidermal melanoblasts migrates into
developing hair matrices before maturation into melanin producing cells; it is
currently unknown, however, whether a fraction of these melanoblasts remain
in the human follicle as stem cells such as is seen in mice. In contrast to
murine melanocytes, both populations of human follicular and epidermal
melanocytes remain active throughout postnatal life in the pigmentation
process, although activity diminishes with aging.

2.1.2 Normal melanocyte morphology and histology
Visualised by bright light microscopy, normal melanocytes have a
rounded cell body with characteristically clear cytoplasm and small round
nucleus (Figure 2.1); their primary function is to produce and distribute
melanin pigments

to adjacent keratinocytes. Visualised

by

electron
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microscopy, long, fine cytoplasmic dendrites can be seen extending from the
soma of the melanocyte (Figure 2.2).

Figure 2.1.

Human Epidermis.

Light microscopy showing normal epidermal melanocyte (indicated by arrow) situated
at the dermal/ epidermal border. Note the characteristic round cell body, round nucleus
and clear cytoplasm.

Figure 2.2. Melanocyte.

Electron microscopy showing melanocyte
with fine dendritic processes.
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In human skin, there is an orderly ratio of one melanocyte per several
keratinocytes, called the epidermal-melanin unit. Once transferred from the
melanocyte, melanin pigm ent accumulates above the nuclei of keratinocytes
within the unit (Figure 2.3). Proliferating and the least mature post-mitotic
keratinocytes are in the basal layer of the epidermis, adjacent to the dermis.
Here, melanin is thought to protect mitotic cells from the ionising effects of
UV irradiation.

Figure 2.3. Epidermal-melanin unit.
Melanocytes distributing melanin among adjacent kerat:inocytes
of epidermal-melanin unit. Arrows indicate cell bodies of the
melanocytes.

2.1.3 Melanogenesis in the Hair Follicle
Melanogenesis refers to the complex process leading to the production
of pheo- and eumelanin pigm ents within melanocytic cells. An intensely
studied form of melanogenesis occurs in conjunction with the growth of new
hair (both in humans and in mice). As the hair follicle cycles through stages of
active growth (anagen), regression (catagen), resting (telogen), and shedding
(exogen), pigment cells also cycle through periods of proliferation, migration,
differentiation and apoptosis (Miiller-Rover et al., 2001) (Figure 2.4).

8

'l'ELOGEN

Figure 2.4. Hair Follicle Cycling.
Diagram depicting hair cycling through stages of
anagen (active growth), catagen (regression) and
telogen (resting).

In mice, the hair follicle contains at least two distinct populations of
melanocytes and melanoblasts; one melanogenic, the other not, respectively
(Tobin et al., 1 995; Tobin & Bystryn 1 996; Nishimura et al., 2002) .
Melanogenically active melanocytes are located in the hair cortex where they
are distributed in close contact with the basal lamina, separating the cortex
and the dermal papilla (Figure 2.5). These cells express tyrosinase mRNA and
actively produce pigment during late anagen (Slominski et al. 1 991; Ortonne &
Prota 1 993); in murine hair, pigment is passed from melanocytes to follicular
kerytinocytes via dendritic processes (Staricco, 1 962; Morrelli et al., 1 991). In
the stages of follicular catagen or exogen, cortex melanocytes have been seen
to retract dendritic extensions before undergoing apoptosis (Tobin et al.,
1 998) . In mice, replacement of these lost cortex melanocytes occurs by
proliferation of a distinct, small population of melanoblasts that remain in an
undifferentiated state, as a stem cell population, within an area known as a
"niche" (Nishimura et al., 2002) . This niche is located in the outer root sheath
of the lower permanent portion of the hair follicle, just below the bulge area
where the arector pili muscle is attached (Nishimura et al., 2002) . Melanoblasts
do not produce melanin or melanosomes and are always maintained in this
bulge area (Nishimura et al., 2002) . Furthermore, in vitro studies demonstrate
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that amelanotic melanoblasts in anagen have extensive proliferative potential.
By contrast, cortex melanocytes are not cultured successfully, suggesting that
these cells are more terminally differentiated (Tobin et a/. 1995; Tobin &
Bystryn 1996).

Figure 2.5.

Hair Follicle.

Within the hair follicle, fully differentiated melanocytes
capable of melanin production are located within the
cortex, above the dermal papilla.

As the hair follicle undergoes transition from telogen to anagen,
melanoblasts migrate out of the stem cell niche to proliferate. At least one of
the daughter stem cells remain in the bulge area while the other migrates into
the developing hair germ where it eventually localises in the cortex, further
proliferates and differentiates into a melanocyte. The reserve of melanocytic
stem cells within the niche is thought responsible for the continued
proliferation of both follicular and cutaneous melanocytes in the mouse
(Nishimura et a/., 2002). In this research, proliferation of murine melanocytic
stem cells from the follicular niche was induced by depilation of normal
murine skin in order to assess Pax3 mRNA expression profiles during
proliferation and migration of melanoblasts.
10

2.1.4 Melanogenesis in the Skin
In human skin, cutaneous melanocytes are located in the epidermis
within the basal layer (adjacent to the basement membrane) where they adjoin
to epidermal keratinocytes via dendritic extensions in order to pass
cytoplasmic melanosomes. It has been estimated that the ratio of melanocyte
to keratinocyte is 1 :40, although thfr- ratio varies according to the area of the
body. Melanisation patterns of human skin reveal that some areas with
concentrated pigmentation are not exposed to UV; this is linked to an
alternate function for melanin as an antimicrobial for skin (Mackintosh, 2001).
In transgenic mice bred to retain functional cutaneous melanocytes,
analysis of induced proliferation has shown that following apoptosis of
cutaneous melanocytes, melanocytic stem cells migrate out of neighboring
hair follicles to proliferate. These cells then migrate further along routes
connecting the follicular outer root sheath and epidermis toward their final
destination within an epidermal-melanin unit (Lei et al, 2002; Nishimura et al,
2002). Similarly, human studies have shown that following treatment of skin
in disorders such as vitiligo (a condition in which skin lacks pigmentation due
to loss of functional melanocytes), re-pigmentation follows a pattern where
pigmented spots first appear in concentric rings surrounding the hair follicle.
With time, these rings enlarge and eventually fuse to recolour the skin
(Nishimura et al, 2002). These two studies imply that follicular melanocytic
stem cells are associated with a continued renewal of lost cutaneous
melanocytes, although research has not demonstrated evidence of a stem cell
population in the human hair follicle to date.

2.1.5 Human Melanogenesis with UV Exposure
Melanin plays an important role in the protection of keratinocytic
cellular DNA by forming a protective envelope around the cell nucleus
(Valverde et al, 1995). It absorbs free radicals generated in the cytoplasm and
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shields the nucleus from various types of ionizing radiation, including ultra
violet (UV) light. In the event of extreme or repeated exposure to UV
irradiation, increased synthesis of melanin is evidenced by "tanned" skin.
Exposure of melanocytes to UV irradiation results in a highly complex
process of DNA repair (Eller et aL, 1994; Barker et aL, 1995; Winter et aL,
2001), upregulation of autocrine and paracrine cytokines (Abdel-Malek et al.,
1995; Imokawa et aL, 1996) and induction of mitosis (Kawaguchi et aL, 2001).
Signalling between UV exposed keratinocytes, melanocytes and fibroblasts
results in an increase in the number, size and dendricity of melanocytes
(Balaban et al., 1988; Grichnik et aL, 1998). Studies have shown that the skin
has precise mechanisms in place both for the prevention of uncontrolled UV
induced melanocytic apoptosis (Allsopp et aL, 1993) and uncontrolled
proliferation within the epidermis (Bacharach-Buhles, 1999).
Controversy has existed as to whether increased numbers of
melanocytes following UV exposure is due to an increase of mitotic activity of
cutaneous melanocytes or due to induction of melanoblasts from a stem cell
population. Rosdahl & Szabo (1978) reported that cell division of established
cutaneous melanocytes is responsible for a 4-6 fold increase in melanocyte
numbers during irradiation. However, only 65-80% of their increased
population were from labelled precursors; they had no explanation for the
origin of the further 20-35% neo-melanocytes.
Using transgenic mice in which cutaneous melanocytes function
postnatally, murine studies have shown that a high percentage of cutaneous
melanocytes undergo apoptosis in response to intense UV exposure. This,
along with cytokine signaling via epidermal keratinocytes in response to
irradiation, promotes migration of melanoblasts from the outer root sheath of
hair follicles (Kawaguchi et aL, 2001; Lei et aL, 2002). Increases of melanoblasts
(not yet capable of melanin production) have been seen in the epidermis on
the first day following UV exposure. Around the fifth day following exposure,
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differentiation of the melanoblasts was evident and resulted in four times as
many melanin producing cells as compared to normal control skin
(Kawaguchi et al., 2001). These studies indicate that intense UV exposure may
overwhelm normal mitotic capabilities of cutaneous melanocytes leading to
apoptosis and further recruitment of stem cells from the niche in order to
replace lost cells.
Undeniably, primary causes for transformation of the melanocytic cell
to neoplasia are numerous and are continuously being investigated. While
many theorise that mutagenic disturbances following intense UV exposure
occur within melanin-producing melanocytes, this study supports the
possibility of UV mutagenesis within mitotic stem cells or post-mitotic
melanoblasts and discusses possible repercussions of this occurance.
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2.2 PRECURSORSOF CMM
Although exposure to UV 1s a principle factor involved in the
acquisition of CMM from benign melanocytic naevus, several studies detail
neoplasia arising due to occurrence of giant congenital melanocytic naevus
and dysplastic naevus syndrome.

2.2.1 Benign melanocytic naevus
A large percentage of CMMs are known to anse from cutaneous
melanocytes within normal skin (Barnhill & Mihm, 1993), however, 40-50%
of CMMs are thought to develop from benign melanocytic naevi (Lopansri &
Mihm, 1979). A benign melanocytic naevus is thought to arise as a
consequence of excessive ultraviolet exposure leading to mutagenesis and
mitogenesis of cutaneous melanocytes. UV mutagenesis of melanocytic cells
can lead to loss of tumour suppressor genes, low-level microsatellite instability
and a reduction in expression of mismatch repair proteins (Alvino et al., 2002;
Hussein et al., 2002; Hussein & Wood, 2003). In any event, these atypical
melanocytes are referred to as naevus cells and they usually develop between
the first and thirty-fifth year of life, undergo specific stages of maturation and
finally senesce (Lund & Stobbe, 1949).
In contrast to normal melanocytes, naevus cells are oval or cuboidal
with large, often vesicular nuclei and clearly outlined cytoplasm; although they
are capable of melanin production, they follow a divergent path of
differentiation eventually expressing proteins similar to those of Schwann cells
(Reed et al., 1999). Within the skin, collections of naevus cells aggregate to
form nests at rete ridges (where the epidermis invaginates toward the dermis)
(Figure 2.6).
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Figure 2. 6. Nest of melanocytic naevus cells. H&E staining. X400

Arrow indicates nest of atypical naevus cells located at the rete ridges of the
epidermis.

At this stage, a benign melanocytic naevus is classified as a 'junctional
naevus'; typically, naevus cells do not extend into the dermis. However, as
naevus cells continue to proliferate and differentiate, post-mitotic cells acquire
the ability to migrate into the dermis. At this stage a benign melanocytic
naevus is classified as 'compound' with naevus cells spanning both the
epidermis and dermis. From this stage, naevus cells become separated from
the epidermis by connective tissue, cease to proliferate and eventually senesce
(Reed et al., 1999).
It is hyp othesised that CMM may anse from nests of benign
melanocytic naevi, either from a naevus cell or from melanocytes adjacent to
or within nests of naevi. Fortunately, most benign melanocytic naevus cells
undergo transition from proliferative to non-proliferative, rendering them
harmless to the carrier. An important phenotypic characteristic of benign
naevus cells is loss of telomerase activity during their transition from
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proliferative to non-proliferative (telomerase activity is necessary during cell
proliferation to prevent telomere attrition). This is in stark phenotypic
contrast to CMM, where neoplastic cells retain the ability to proliferate due to

increased telomerase activity (Rudolph et al., 2000).
This begs the question, do benign naevus cells diverge from the benign
differentiation pathway to become CMM; for example, is each cell able to
change from one pathway to the other? While this theory is feasible, an
alternate explanation for phenotypic differences between benign melanocytic
naevi and CMM may be that mutagenesis of mitotic or post-mitotic cells
results in cellular differentiation down one pathway or the other, both being
mutually exclusive and randomly occurring within the cell.

2.2.2 Congenital Naevi
Another precursor of CMM is thought to be a congenital naevus,
present at birth and affecting 1-2% of neonates (Walton et al., 1976). A
congenital naevus appears as a brown or black round or oval plaque, often
associated with overgrowth of hair (Figure 2. 7). The naevus may be small
(15mm), medium (15-199mm) or giant (> 200mm) and comprised of the
following cell types in any combination: melanocytic naevi, neuroid naevi
(naevus cells expressing nerve sheath proteins), blue naevi, and/ or cellular
blue naevi.
While a small congenital naevus is associated with a 3% risk of
transformation, a giant congenital naevus has a 15% risk of developing into
CMM before the age of pubescence (Dellon et al., 1976). Furthermore,
statistics have shown that 40% of CMM cases seen in children arise from
giant congenital naevus (Dellon et al., 1976; Quaba & Walllace, 1986).
Although there is no known genetic contribution to date, it has been
suggested that a number of cases of congenital naevus may be determined by
an autosomal dominant gene of variable expressivity (Goodman et al., 1971).
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As melanocytes of human skin are thought to be clonally derived from a small
population of primordial melanocytic stem cells which migrate in a standard
pattern such as the murine melanocytes seen in Mintz' work (see pg. 17),
mutagenesis of mitotic stem cells or post-mitotic primordial melanoblasts may
be a plausible explanation for development of giant congenital naevi (Figure
2.7).

Figure 2. 7. Congenital melanocytic naevus.

Infants with giant congenital naevus. Removal of the
naevus requires several extensive surgeries.

2.2.3 Dysplastic naevus syndrome
10% of CMM cases are familial and suggest an inherited predisposition
(Fountain et al, 1990). One such predisposition may be dysplastic naevus
syndrome, an autosomal dominant inherited disposition in which affected
individuals develop 10-100 large naevi following puberty (Haley et al,
2000)(Figure 2.8).
In comparison to benign melanocytic naevus cells, cells of a dysplastic
naevus are increasingly atypical relative to normal melanocytes. Following a
progression of developmental stages similar to benign naevus cells, the
dysplastic naevus cells divert at migration into the dermis. Here cells continue
to proliferate, synonymous with increasing atypia, hyp erplasia, hyp ertrophy
and dysplasia. Histological criteria for diagnosis of dysplastic naevus syndrome
are lamellar and concentric dermal fibroplasia, presence of dermal
lymphocytic infiltrate and elongation of rete ridges (Elder et al, 1982; Kraemer
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& Greene, 1 9 85) . Furthermore, dysplastic naevus cells have significantly larger
nuclei, consistant with a hyp erdiploid or tetradiploid DNA content.

Figure 2.8. Dysplastic Naevus Syndrome.
Note the number of naevi present on the trapezoidal region of the back.
Arrows indicate suspect melanomas. Circled naevi are examined for
growth and color changes over time. Persons with this syndrome are
considered highly susceptible to development of CMM.

Dysplastic naevus is known to be a precursor of many cases of CMM;
in fact persons inheriting dysplastic naevus syndrome are highly susceptible to
CMM (Greene et al., 1 985; Bale et al., 1 986) . Two principal loci known to be
associated with dysplastic naevus syndrome are at 1 p (the gene locus called

CMM1) and 9p (the gene locus called CMM2) . Through multipoint linkage
analysis, Bale et al. (1 989) mapped CMM1 to 1 p36. Patients carrying a
mutation at this locus have distinctive characteristics of the skin, closely
resembling xeroderma pigmentosum (a syndrome in which individuals possess
a defect in DNA-repair mechanisms) . It has recently been shown that reduced
DNA-repair ability combined with presence of dysplastic naevi syndrome is
strongly associated with risk of CMM and may contribute to susceptibility to
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sunlight-induced CMM (Landi et al., 2002).
The CMM2 locus at 9p21 contains several candidate genes for CMM
(Puig et al., 1995). Chromosome region 9p21 is involved in homozygous
deletions in more than half of all melanoma cell lines (Kamb et al., 1994). The
region was found to contain the gene CDKN2A which encodes an inhibitor
of cyclin-dependent kinase-4 (CDK4) (Serrano et al., 1993; Kamb et al., 1994) .
Complexes formed between CDK4 and cyclins are involved in the control of
cell proliferation during the G1 phase. In familial melanomas it has been
established that a mutation in the CDKN2A gene leads to a marked increased
risk for CMM, although a number of 9p21-linked kindred lack germline
coding mutations in CDKN2A (Loo et al., 2003).
In summary, deficiency in mutation excision repair systems is strongly
linked to development of CMM, particularly when an affected individual is
subjected to extreme UV exposure. CMM arise from normal skin or an
existing benign melanocytic naevus; persons possessing either congenital
naevus or dysplastic naevus are at an increased risk. In the case of congenital
naevus, risk of developing CMM has not been linked to a particular mutation.
By contrast, in dysplastic naevus syndrome, mutations in CMM1 at 1 p36 or

CMM2 at 9p21 have been identified; however, many persons with dysplastic
naevus syndrome do not possess either mutation and yet develop CMM while
many persons with dysplastic naevus syndrome harbouring a known mutation
in either 1 p36 or 9p21 do not develop CMM. Although mutations in PAX
genes are associated with many forms of cancer (Bennicelli et al., 1996; Iida et
al., 1996; Kroll et al., 2000), these studies have demonstrated that causative
mutations in CMM are not associated with PAX3.
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2.3 CUTANEOUS MALIGNANT MELANOMA ------CMM tumours are classified into five histologic types: lentigo maligna
melanoma, superficial spreading melanoma, nodular melanoma, acral
lentiginous melanoma and desmoplastic melanoma. As the desmoplastic
variety of tumour is very rare (McGovern & Murad, 1 985), discussion will
focus on the four most common types of CMM.

2.3.1 Lentigo Maligna Melanoma
Lentigo maligna melanoma arises from a noninvasive malign ant lesion
(also known as Hutchinson's freckle). Lentigo malign a develops as a tan or
brown macule with uneven, superficial black spots on sun-exposed areas of
the body such as the face (Figure 2.9). Lentigo maligna melanoma occurs with
an incidence of approximately 7% of CMMs (Davis, 1982, pg. 72). The
condition is diagnosed most often in the elderly, as lentigo maligna usually
arises in the fourth decade of life or later; there is a slow, insidious
development of malignancy over a period of rarely less than 20 years (Davis,
1982, pg. 72). A notable increase in size, darkening and/or bleeding of a
lentigo maligna lesion heralds the change from noninvasive to invasive
growth.

Figure 2. 9. Lentigo maligna melanoma.

Note the irregular border and dark brown areas which are
characteristic of the lesions.
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2.3.2 Superficial Spreading Melanoma
Superficial spreading melanoma is the most common form of CMM,
estimated to account for 55-75% of all of CMMs (Davis, 1 982, pg. 72).
Superficial spreading melanoma can be diagnosed at any age; however it
usually begins in middle age. Although these lesions can occur anywhere on
the body, they most commonly appear on the lower legs of women and torsos
of men. Lesions are irregular, raised plaques, multicoloured with white, red,
blue or black areas and blue-black nodules (Figure 2.1 0). Horizontal growth
may continue for several years (as lentigo maligna does for decades) before
invasive vertical growth into the dermis.

Figure 2.10. Superficial spreading melanoma.
The multi-coloured appearance is characteristic of
the lesion.

2.3.3 Acral-Lentiginous Melanoma
Acral-lentiginous melanoma arises on the palmar, plantar and
subungu al tissues, notably the distal phalanges of the fingers and toes (Figure
2.1 1 ). It is the least common type of CMM, accounting for approximately 1 %
of CMMs (Davis, 1 982, pg. 74).

Acral-lentiginous melanoma initially

manifests as an irregular brown or black macule on the sole, palm, digit or
nail-bed and is often mistaken for a haematoma or fungal infection.

21

Histologically,

acral-lentiginous

melanoma

resembles

lentigo

maligna

melanoma and shares a similar lengthy stage of non-invasiveness. Subungu al
acral-lentiginous melanoma cannot be staged using thickness criteria, as
invasive growth is noted histologically by nail erosion, scaling, furrowing or
elevation. Eventually the subungu al acral-lentiginous melanoma ulcerates to
push the nail aside. Although acral-lentiginous melanoma is the least common
of the four types of CMM, it is the most common melanoma of non-white
persons (Davis, 1982, pg. 74).

Figure 2.11. Acral-lentiginous melanoma.

Lesions located in the nail-bed of thumb (A) and plantar surfaces (B, C) of the
foot.

2.3.4 Nodular Melanoma
Nodular melanoma (Figure 2.12) is the second most common type of
CMM (15-30%) with a very high risk of metastasis due to aggressive, invasive
vertical growth of the nodule (Davis, 1982, pg. 72). An increase in lesion
pigmentation usually precedes nodular enlargement; eventual ulceration and
bleeding are late signs of malignancy. Nodular melanoma is histologically
characterised from other types of CMM by its nodules of large, epithelioid
melanocytes expanding exclusively in a vertical manner into the dermis
(Davis, 1982, pg. 72).
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Figure 2.12. Nodular melanoma.

2.3.5 Histopathology of CMM
Transformation of the normal melanocyte to neoplasia leads to a
relatively uniform progression of cellular pathology. Morphologically, CMMs
may contain cell types that are epithelioid (rounded) or lentiginous (spindle)
shaped. Tumours with predominantly epithelioid shaped cells tend to organise
atypical cells into "nests" whereas tumours with spindle shaped cells organise
into irregularly branched formations. The histopathological features in the
early stages of CMM show an accumulation of neoplastic cells in the
epidermis above the basement membrane; at this stage the lamina may or may
not be intact, however the tumour is thought to have no metastatic potential
due to inaccessibility of blood vessels and lymphatics situated below the
basement membrane.
As the neoplasm continues to develop, cells penetrate the papillary
dermis (fingerlike projections of the dermis between the rete ridges of the
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epidermis) . In the earliest portion of this stage, only single neoplastic cells
invade the papillary dermis; therefore, the metastatic potential of the lesion is
still considered to be zero. Following invasion of the papillary dermis, tumour
cells acquire the ability to proliferate in the cellular and stromal environment
of the dermis. Proliferating intra-dermal tumour cells aggregate into multi
celled populations that continue to expand to the level of the reticular dermis.
At this stage, an initial, slight risk of metastasis exists, gradually increasing as
the tumour invades deeper into the dermis. Once CMM invades the reticular
dermis and eventually the subcutaneous fat, the risk of metastasis is great and
visceral metastases are likely to occur.

2.3.6 Diagnosis/Staging of CMM
There are currently two systems employed to grade or stage CMM. The
Breslow system (Breslow, 1 97 5) is based on the total thickness of the tumour
as measured from the outermost layer of the stratum granulosum to the
deepest point of tumour invasion into the dermis during the vertical growth
stage. This measurement has a strong predictive value in the prognosis of
patients with non-metastatic melanomas (Table 2) . The Clark system (Clark et

al., 1 97 5) grades a tumour according to depth of invasion of atypical cells or
inflammatory infiltrates in relation to cutaneous histologic structures and
correlates prognosis to the anatomic level of involvement (Table 3) .
Table 2. The Breslow system of tumour grading/prognosis (Breslow, 1975).

Total thickness of tumour

Five Year Survival Rate

0.00-0. 7 6mm

98-99%

0.76-1.49mm

85%

1 .50-2.49mm

84%

4.00mm

44%
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Table 3. The Clark system of tumour grading/prognosis (Clark et al., 1975).

Clark System

Five Year Survival Rate

Level I-Tumour is confined to the

100-98°/o

epidermis and is above the basement
membrane

Level II- Invasive cells are present

96-72°/o

solely in the papillary dermis

Level III- Tumour cells are seen

90-46°/o

throughout the papillary dermis with
impingement on the reticular dermis

Level IV- Tumour cells are seen

67-31%

between collagen bundles of the
reticular dermis

Level V- Tumour cells are seen m

48-12%

the subcutaneous fat

Following diagnosis of CMM, subsequent measures attempt to discern
whether the cancer remains localised or has metastasised. The presence of
metastases leads to a particularly unfavorable prognosis for the patient as
CMM proves resistant to many conventional therapies. CMM progression has
been the focus of much study and a review of these studies in its entirety
would be insurmountable; therefore, this review is focused on events of
progression thought potentially related to PAX3 expression.
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2.4 PAX3/ Pax3 EXPRESSI 0N ------------Nine members of the PAX family of genes derive their name from a
384 hp DNA paired box sequence that encodes a highly conserved DNA
binding domain termed the paired domain (Burri et al., 1989; Krauss et al.,
1991). PAX genes are further classified into groups (I-IV) according to
possession of a full or partial homeodomain, another important DNA binding
domain. (Figure 2.20). The PAXJ gene, located at 2q35 (Ishikiriyama, 1993),
encodes a class II.I PAX protein transcription factor.

2.4.1 Pax3 in Embryogenesis
Pax3 is amongst the earliest transcription factors functioning during
embryogenesis (Goulding et al., 1991). Within the neural tube, it is expressed
in cells that specify dorsal neurons (Goulding et al., 1991) and plays a role in
neural tube closure (Li et al., 1999).
Pax3 expression is also required for survival and migration of myogenic
precursor cells. In mice, Pax3 is expressed in early somites as segmentation of
the paraxial mesoderm occurs (Goulding et al., 1991; Maroto et al., 1997;
Heanue et al., 1999). Expression in cells of the medial lateral edge of somites
denotes early stages of myogenic cell specification and cells arising from the
hypaxial portion of the dermamyotome (medial lateral portion of the somite)
migrate laterally to enter limb bud regions where they become limb
musculature (Goulding et al., 1991; Williams & Ordahl, 1994; T remblay et al.,
1998; Henderson et al., 1999; Lamey et al., 2004).
Finally, Pax3 functions in specification and migration of neural crest
derived cells fated to become enteric ganglia (Lang et al., 2000), heart septum
(Li et al., 1999), Schwann cells (Kioussi et al., 1995) and melanocytes of the
skin and hair follicles (Galibert et al., 1999). As stated previously, melanoblasts
are derived from the neural crest where Pax3 is expressed in melanoblast
precursor cells prior to their migration from the neural crest (Galibert et al.,
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1999). PAX3/Pax3 is thought to function in both proliferation of
melanoblasts (Hornyak et al., 2001) and differentiation of melanocytes through
regulation of gene expression involved in melanin production (Galibert et al.,
1999).

2.4.2 Pax3 Mutations
The role of Pax3 has been largely determined by studies in Pax3 mutant

Splotch mice (Figure 2.13). The name 'Splotch' refers to melanocytic defects
resulting in splotchy pigmentation abnormalities of the fur. Homozygous
Splotch mice (PaxJ-1) die at embryonic day 1 4 due to neural tube defects in the
lumbosacral region leading to spina bifida and exencephaly (Fleming & Copp,
1998; Moase & Trasler, 1992). In a study done in 1999, Splotch mice with
transgenic Pax3 expression in the neural tube and neural crest demonstrated
rescue of neural tube closure and these mice did not have exencephaly (Li et

al., 1999).
In the Splotch mouse, mutations in Pax3 affect myogenesis due to a
failure of myoblasts to migrate into the limb buds (Bober et al., 199 4; Franz et

al., 1993). In transgenic mice with inhibited Pax3 expression in the somites,
pups reveal absence of diaphragm, supraspinatus, infraspinatus, subscapularis,
terres minor and all distal limb muscles, consistent with the finding that
hyp axial muscles arise from Pax3+ cells of the lateral somites (Li et al., 1999).
Mutations in Pax3 also lead to a number of neurocristopathies. Lang et
al (2000) compared development of Splotch mice to transgenic mice in which

Pax3 expression was restored to the neural tube and neural crest. Analysis of
these pups demonstrated that where Pax3 expression was restored, embryos
showed enteric ganglion formation. Furthermore, Splotch mice have cardiac
defects due to failure of septation in the truncus arteriosus (Epstein et al.,
1996; Franz et al., 1989). Li et al. (1999) demonstrated that transgenic Splotch
mice with re-expression of Pax3 in the neural crest restored cardiac flow
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septation and promoted survival until birth.
Finally, Pax3 mutations result in hearing, craniofacial and pigm entation
anomalies which demonstrate variability in penetrance and expressivity.
Asher et al. (1 996) stated that a minimum of two genes, one of these being
either X-linked or sex-influenced and the other autosomal, interact with the
Splotch Pax3 mutation to influence the craniofacial features of Splotch mice and
concluded that further studies may lead to identification of genes that interact
in order to modify the expression of human PAX3 mutations in Waardenburg
syndrome.

Figure 2.13. Photomicrograph of a Splotch Murine Embryo.

The mouse embryo on the left is a Pax3 mutant "Splotch" mouse. Note the
defects in the area of the neural tube, neural crest derived cranial facial structures
and limb bud formation as compared to the wild type mouse on the right.
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2.4.3 PAXJ Mutations
Mutations in human PAX3 are associated with Waardenburg syndrome
Typ e 1, an autosomal dominant condition that presents with deafness ana
pigmentary disturbances due to dysfunction in the proliferation of neural crest
derived cells (Tassabehji et al., 1 993). Mutations in PAX3 encode abnormal
transcription

factors

that

are

unable

to

regulate

transcription

micropthalmia-associated transcription factor (MITF). MITF functions

of
ill

survival of melanoblasts and synthesis of enzymes involved in melanogenesis;
therefore, loss of MITF results in the absence of functioning melanocytes in
the stria vascularis and hair follicles (Figure 2. 1 4) (Bentley et al., 1 994; Ganss et
al., 1 994; Yasumoto et a/., 1 994; Tachibana et a/., 1 996) .

Figure 2. 14. Children affected
Waardenburg Syndrome I.

by

The white forelock is a pigmentation
defect in the hair follicles due to absence of
melanocytes.

It can be seen from mutation studies that PAX3 /Pax3 plays an
important role in the early development of particular lineages, most likely
being associated with cellular proliferation, migration and/ or regulation of the
migratory phenotype of Pax3 expressing cells. In CMM, PAX3 mutations do
not occur; rather, aberrant expression of a particular isoform is demonstrated.
Knowing this led to the hyp othesis that the developmental role of PAX3 may
be re-activated in CMM and thus contribute to neoplastic progression.
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2.4.4 Alternative PAX3Transcripts
Functional diversity of PAX3/ Fax3 in vivo is linked to its ability to
produce alternatively spliced gene products which alter the structure and
consequently the binding activity of the paired and homeodomain regions
(fsukamoto et al., 1994; Underhill & Gros, 1997; Seo et al., 1998). Originally
FAX3 was thought to contain only eight exons. Recent studies show that
PAX3 / Fax3 may be alternately spliced at exons 4, 5, 8, and 9 to produce
many different transcripts including transcripts that lack an entire homeobox
(Parker et al., 2004; Pritchard et aL, 2003; Barber et al., 1999; Tsukamoto et al.,
1994) (Figure 2.15).
Pax3a

Pax3b

Pax3c

10

Pax3d

Pax3e

Pax3f
Figure 2.15. Alternate transcripts of P.AX1 produced by alternate splicing.
An arrow for each transcript indicates the predicted locations of translation
termination. Pax3a and Pax3b) These transcripts lack the entire homeobox and 3' end
(Tsukamoto et al., 1 994). Pax3c) Transcript containing 8 exons and a stop codon 5 hp
into intron 8 (Goulding et al., 1 991). Pax3d) Transcript contains exon 9 spliced directly
onto 3' end of exon 8 (Barber et al., 1 999). Paxe) transcript containing 1 0 exons Barber
et al., 1999). Pax3f) transcript found in murine cDNA that contains exon 9 directly
spliced to the 3' end of exon 5 Barber et al., 1999).
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Alternate transcripts are likely to encode proteins with different binding
and transactivation activities therefore having an important effect on the
functional role of the gene (Underhill & Gros, 1997; Fortin et al., 1998)
Generation of differing transcripts of PAX3/Pax3 is accomplished by post
transcriptional pre-mRNA splicing and central to this research was the
identification and analysis of constitutive and cryptic splice sites that generate
alternate PAXJ/ Pax} transcripts found expressed in various tissues.
Therefore, an intricate understanding of splice site consensus sequences,
splice site selection and splicing machinery involved in pre-mRNA processing
was essential to understand the observed PAXJ/Pax} transcript expression
profiles in CMM, murine embryogenesis and specifically melanogenesis.

2.4.5 Generation of Alternate PAX3Transcripts
RNA splicing is dependent on the existence of consensus sequences
located at exon/intron boundaries and within the intron itself. Small nuclear
ribonucleoproteins (snurps) and splicing factors bind to consensus sequences
leading to assembly of the splicing machinery (sliceosome). Briefly, base
pairing of the U1 snurp occurs at the 5' splice site consensus sequence
GUA/GU located at the exon/intron border and this signals subsequent
events (Mount et a!., 1983; Black et a!., 1985; Watakabe et a!., 1992). The U2
snurp then binds to the branchpoint sequence CTA/GAC/T within the
intron causing the adenosine residue to bulge out, forming a lariat structure
(Pikielny et al., 1986; Cheng & Abelson, 1987; Konarski & Sharp, 1987;
Zhuang et al., 1989). Further splicing factors bind to a polypyrimidine tract
(PPT) located within the intron (Green et al., 1991). Finally, snurps U4, US
and U6 bind to the 3' consensus sequence YAG (Y is a pyrimidine) located at
the intron/exon border (Pikielny et al., 1986; Konarski & Sharp, 1987; Cheng
& Abelson, 1987) (Figure 2.16A).
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Figure 2.16 Initial pre-mRNA splicing.
A.) Assembly of the spliceosome. Exons denoted by boxes, intron indicated as a
solid line; consensus sequences are letters along line; snurps and splicing factors are
coloured circles.
B.) Step one of intron excision. Assembly of the spliceosome causes
conformational change of the gene such that the 2' OH of the bulged out branchpoint
adenosine is able to disrupt the phosphodiester bond (P in circle) at the 5' splice site (blue
arrow indicates disruption of phosphodiester bond)

The excision process occurs in two steps. Step one occurs as assembly
of the spliceosome causes conformational change of the pre-mRNA such that
the 2' OH of the branchpoint adenosine is able to disrupt the phosphodiester
bond at the 5' splice site, releasing the upstream exon and forming the lariat
intron intermediate (Figure 2.1 6B) . Step two proceeds as the hydroxyl group
of the cleaved upstream exon attacks the phosphodiester bond at the 3' splice
site (Figure 2.1 6C) resulting in displacement of the lariat intron and ligation of
the two exons (Figure 2.1 6D) .
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Figure 2. 16 (cont).

Final pre-mRNA Splicing.
C.) Diagram depicting release of upstream exon (red box), formation of lariat
intron (loop on left), and disruption of 3' phosphodiester bond (P in circle); blue arrow
indicates proximity of OH of cleaved upstream exon to 3' bond. Step two proceeds as the
hydroxyl group of the cleaved upstream exon attacks the phosphodiester bond at the 3'
splice site resulting in displacement of the lariat intron and ligation of the two exons.
D.) Diagram depicting release of lariat intron (on left) and ligation of exons
(coloured boxes).

Normally, RNA processing gu arantees that the 5' donor site· pairs with
the closest 3' acceptor site. Many genes, such as PAXJ, however, have
sequences which are ambiguous, therefore the spliceosome may search for
additional splice site choices up or downstream from ambiguous sequences.
The function of gene splice site selection is thought linked to production of
tissue specific transcripts, although mechanisms for splice site selection are
presently unknown.

2.4.6 PAX3C and PAX3D Transcripts
PAXJC mRNA is transcribed from exons 1 -8. The sequence for the 3'

end (beginning at exon 8) is shown below and is generated using the stop
codon and polyadenylation sign als located within intron 8 (Figure 2. 1 7) .
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AGGTAATGGG ACTCCTGACC AACCACGGTG GGGTACCTCA TCAGCCCCAG ACTGATTACG

CGCTCTCCCC TCTCACCGGG GGTCTGGAAC CTACCACCAC GGTGTCGGCC AGCTGCAGTC
AGAGACTAGA CCATATGAAG AGCTTGGACA GTCTGCCAAC ATCTCAGTCC TACTGTCCAC
CCACCTATAG CACCACAGGC TACAGTATGG ACCCTGTCAC AGGCTACCAA TATGGGCAGT
ATGGACAAAg taagccttgg actttttagg gggcaatttc tcctggaagg gagataaact

caactcttcc ttaagaaagg tgaattagag gcaagattaa gccacacatg ccggtatcaa
tttttttttt tgcaaagcca gctgactgtt ccagcagggg cttccttgtg taattatttt
cttaactgat gtcaacaaca tcttgcggtt attaattgtt gagacgtgaa acctgattgc
cactaggtaa aacacaaggg ttggccaaaa tgaaataatc cctgacatta gaaacacatg
ttcttaatga ggtcagctcc aggatcatat gggggataat cccagggaca caaagttgtg
tcaaacttgt ctcaggaata aaaatattag tctcaagcct ttgatagcac ggtattaaat
atgacattgt cagcctgtag ctgatcttgc ccctgactgt gaattgtccc agcatgacct
aaaaagctgc gtgtgtttcc

cagGTGC CTTTCATTAT CTCAAGCCAG ATATCGCGTA

AGTGAACTGT CCACTTGGAG CTAAAACTGG CCCTGTTTCT GGTCTTCGCA GCCTAGATAT
GAAGAATCTG CTCTGAAAAC AAAAAAAAAT TACCCTITTG TTGGGGGGGG TGGGGCAGTG
GTCCCAATAG GAGACAAAGG AGAGTGATTG ATITICTTCC TCCAATAGTT GGTTTCAAAT
CCTITTGAAC ACGTTCGACA AAAGCAGTGG AGAAGAGGAA GACCTGGAGC AATAAA

Figure 2. 17. Differing generation of the PAX3C and PAX3D transcripts.
Shown is the genomic sequence of PAX3, from exon 8. Exons 8 and 9 are denoted by
large case letters while the intronic region is denoted by small case. In generation of the
PAX3C pre-mRNA, splicing machinery recognises a signal for cleavage and adenylation
located within the intronic region (indicated in red). In generation of the PAX3D pre-mRNA
transcript, splicing machinery ignores the first signal for cleavage and polyadenylation used for
PAX3C (in red) and continues transcription until the signal for cleavage and adenylation at the
sequences indicated by pink lettering. This longer pre-mRNA will then be spliced at S' and 3'
consensus donor/ acceptor sites (indicated in blue) utilising the branchpoint sequence and
polypyrimidine tract indicated by green and orange lettering, respectively.

PAXJD mRNA is transcribed from exons 1-9 and has been found
highly expressed in CMM, yet not expressed in normal skin (Barr et al., 1 999;
Scholl et al., 2000). The donor site for intron 8 is located 11 nucleotides
upstream of the PAXJC stop codon with intron 8 branchpoint,
polyp yrimidine tract and acceptor site located downstream. In generation of
the PAX3D transcript, splicing machinery ignores the first signal for cleavage
and polyadenylation used for PAXJC and instead continues transcription
producing a longer pre-mRNA

that will be spliced at alternative

donor/ acceptor sites. It is interesting to note that the PAXJD splice sites are
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Analysis of the generation of varying PAX3 /Pax3 isoforms was a focal
point of this study as the predominant isoform expressed in CMM is the
PAX3D isoform (Barr et aL, 1999). This being the case, it was thought curious
that mRNA transcription in CMM utilises the weaker splice elements
continuously over the constitutive splice sites. Therefore, the expression of

Pax3d has been examined during stages of murine embryogenesis and
melanogenesis to understand its possible significance in CMM.

2.4. 7 PAX3 and CMM
Results from previous studies have raised the possibility that PAX3
regulated developmental programs may be at work in CMM cells and that
neoplastic melanocytic cells may be functioning in a manner similar to
pluripotent embryonic neural crest cells. The first indication that PAX3
regulated developmental programs may be involved in the progression of
CMM is the strong expression of PAX3 in CMM cells, whereas little or no
expression is observed in normal adult melanocytes (Scholl et aL, 2001).
Although mutations in PAX genes are associated with many forms of cancer
(Bennicelli et al., 1996; Iida et al., 1996; Kroll et al., 2000), this is not the case in
CMM, where causative mutations are at gene loci other than those of the

PAX gene family. However, of note is the increased expression and aberrant
expression profile of PAX3 transcripts in CMM.
Aberrant expression of PAX3 in CMM was first detected by Barr et al.
(1999), who reasoned that expression of PAX genes in neural crest
progenitors might be repeated in tumour cells arising from the same lineage.
Using RNAse protection assays to quantify PAX3 expression in both cell
lines and tumour tissue from CMM, they found that levels of PAX3 were
"notably high". They also observed the predominant transcript found
expressed in CMM was the PAX3D transcript, although PAX3C is also
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expressed. These findings raised the possibility that the phenotype of CMM
may be related to increased aberrant expression of PAX3D.
No published studies

(to date) have identified expression of

PAX3D/Pax3d or their encoded proteins in normal melanocytic tissues;
therefore, it is not yet known whether this protein has a particular role in
transcriptional regulation of the melanoblast. Differences in the structure of
the C-terminal region of PAX3/Pax3 isoforms influence protein-protein
interactions of transactivational domains and thus transcriptional activation of
downstream targets bound by PAX3 /Pax3 via its paired DNA binding
domain.

Therefore, a primary aim of this research was to investigate

PAX3C/PAX3D and Pax3c/Pax3d expression profiles in CMM and murine
tissues hoping to gain insight into a possible role for PAX3C/Pax3c and
P AX3D /Pax3d proteins.

2.4.8 PAX3 Mediated Transcriptional Activation
Transcription factors such as P AX3 /Pax3 reqwre two functional
domains within their protein structure to assist in transcription of target genes
into RNA. Firstly, a DNA binding domain must recognise and bind specific
regulatory sequences within promotor/ enhancer regions of the target gene
DNA; secondly, the transactivating domain of the transcription factor protein
associates

with basal

transcriptional machinery and influences gene

expression. Furthermore, the transactivation domain functions to recruit
components of the pre-initiation complex, other transcription factors or
transcriptional machinery to the area of the gene promotor, facilitating the
formation of the protein-DNA complex which sign als RNA polymerase to
begin initiation and transcription of the gene (Ptashne, 1988; Mitchell & Tijan,
1989). The PAX3C/PAX3D and Pax3c/Pax3d isoforms analysed in this study
vary only in the length and composition of their transactivation domains. The
alternate C' end may confer different transcriptional ability to PAX3 binding
domains or they may be associated with varying DNA target selection.
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2.4.9 PAX3 DNA Binding Domains
PAX3/Pax3 has two DNA binding domains within its structure, a
paired domain (PD) and a paired type homeodomain (HD) (Figure 2.20).

PO

HD

TD

Figure 2.20. Molecular structure of the Pax3 protein.
Pax3 protein contains a paired domain (PD)
consisting of PAI (N) and RED(C) subdomains, each of
which is composed of three helices in a helix-tum-helix
motif. The third helix of each subdomain is shown in
contact with the target DNA. The Pax3 protein also
contains an octapeptide (OP) followed by a
homeodomain (HD) containing an additional helix-turn
helix DNA binding domain. Finally, the transactivation
domain (TD) is indicated.
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Structural analysis has revealed that the PD consists of two
independent helix-tum-helix subdomains, an N-terminal (PAI) and a C
terminal (RED) (Xu et al, 1995). Mutations in the PAI subdomain result in a
loss of both PD and HD binding (Underhill et al, 1995; Fortin et al, 1997;
Underhill & Gros, 1997) perhaps due to loss of crucial major and minor
groove DNA contacts (Xu et al, 1995) . The RED subdomain has been shown
to be dispensable for binding in deletion studies (Wilson et al, 1993;
Miskiewicz et al, 1996); however, more recent studies detailing distinct PD C
terminal subdomain sequence preferences amongst Pax family members
suggests that this subdomain may be used for discrimination of DNA targets
(\!ogan & Gros, 1997) .

The 61 amino acid HD conforms to a helix-tum-helix motif (Wilson et
al,

1995) and is able to bind DNA both monomerically recognising an ATTA

motif and as a dimer utilising a palindromic motif of 5' TAAT(N) 2_3ATTA 3'
(Wilson et al, 1993) . It is suggested that binding of the initial HD cause DNA
distortions thus preparing a template for further binding by the second HD.
Because the binding affinity of the HD as a monomer is considered weak,
homodimerisation of the HD is thought to enable recognition of target
sequences long enough to ensure further binding specificity and affinity
(Wilson et al, 1995).
Alone, the 128 amino acid PD recognises a GTCAC binding motif
(Epstein et al, 1993; Chalepakis & Gross, 1995) . However, when binding in
conjunction with the homeodomain, the paired domain recognises either a
GTTCC motif (Chalepakis et al, 1994) or a GTTAT motif (Phelan & Loeken,
1998) located downstream of the consensus homeodomain motif of ATTA.
Paired and homeo- DNA binding domains have been seen expressed
separately in Caenorhabditis elegans, suggesting functional independence
(Chisholm & Horvitz, 1995; Zhang & Emmons, 1995). However, mutations
of the PD in the human PAX3 protein such as those seen in Waardenburg
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syndrome have been shown to affect or abrogate DNA binding by the HD,
signifying that the two domains function interdependently (Baldwin et al.,
1995; Fortin et al., 1 997). Moreover, in vitro binding studies have illustrated
cooperative interactions between the PD and the HD of P AX3 Qun &
Desplan, 1996; Vogan & Gros, 1997; Underhill & Gros, 1997; Fortin & Gros,
1998).
To further illustrate the complexity involved in PAX3 target gene
selection and binding, recent studies have demonstrated that PAX3 interacts
with other factors to activate promotor and enhancer regions of downstream
target genes. For example, Sox10 and Pax3 synergise to activate the c-RET
gene enhancer (Lang et al., 2000). Pax3 and Sox1 0 physically interact with each
other through contacts mediated by the PD while at the same time Pax3 binds
the c-RET enhancer via a PD-DNA protein interaction (Lang & Epstein,
2003). In contrast, SOX10 and PAX3 must bind DNA recognition elements
independently in order to synergistically upregulate the MITF gene promotor
(Bondurand et al., 2000). In this interaction, PAX3 binds DNA utilising the
HD (Lang & Epstein, 2003). In summary, it is notable that PAX3 interacts
with the c-RET enhancer via PD-DNA interactions, while it binds the MITF
promotor via HD-DNA interactions. This illustrates

how alternate

P AX3/Pax3 proteins may play different roles to activate different
downstream gene targets during development and CMM.

2.4.10 PAX3 Trans activation Domains
It is now generally accepted that transcription factors function through
the transactivating region of the protein by interaction with proteins of the
basal transcriptional machinery including RNA polymerase II (Ptashe &
Gann, 2002). There is strong evidence that the mechanism by which trans
activators function is via "recruitment". The recruitment model of
transcriptional activation states that the trans-activation regions of the
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transcription factor serve to attract the basal transcription complex to the
vicinity of the promotor region of the gene leading to a signal for polymerase
II to initiate transcription (Barberis et al., 1995; Gaudreau et al., 1998;
Keaveney & Struhl, 1998).
The transactivation domain of PAX3 /Pax3 is located within the last 78
COOH-terminal amino acids and is classified as a praline-serine-threonine
(PS1) activation domain due to the amino acid composition (Chalepakis et al.,
1993). COOH-terminal deletion studies of PAX3/Pax3 further support the
recruitment model; these studies have shown that deletion of part or the
entire COOH transactivation domain of PAX3/Pax3 results in the failure of
mutant proteins to tran-sactivate reporter genes (Chalepakis et al., 1994;
Bondurand et al., 2000; Cao & Wang, 2000; Pritchard et al., 2002). Similar
results were obtained in a study in which the transcriptional competence of
Pax2, PaxS and Pax8 were eliminated via a frameshift mutation in the
transactivating region of the protein (Dorfler & Busslinger, 1996).

2.4.11 PAX3 and the Basal Transcriptional Complex
To date there are no studies demonstrating a direct interaction between
the transactivating region of PAX3/Pax3 and the basal transcriptional
complex. However, Smit et al (2000) demonstrated an interaction of Pax3,
Sox10 and Bm-2 cofactors with TATA-box-binding protein and p300, two
components of the basal transcriptional complex. Cvekl et al (1999) also
demonstrated protein-protein interactions of the C-terminal-activation
domain of Pax6 with the TATA-binding-protein.
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2.5 MELANOCYTIC SURVIVAL FACTORS -------Since PAXJ is over-expressed in CMM, an investigation of possible
candidate downstream target genes was undertaken. Review of key
developmental genes involved in melanogenetic events as well as evidence
suggesting c-KI.T and MJTF may be probable cofactors or downstream targets
of PAXJ in melanoblast proliferation, migration or differentiation prompted
further investigation of their co-expression in this study.

2.5.1 The c-K/TGene
The c-KI.T gene encodes a receptor tyrosine kinase which, along with its
ligand, stem cell factor (SCP), has been shown to play a crucial role in the
survival and migration of melanoblasts. Expression patterns of SCF have
suggested that c-Kit/SCF mediates migratory or chemotactic processes for c
Kit expressing cells.
In the embryo, neural crest cells initially produce SCF, which functions
in an autocrine fashion to induce melanogenesis in adjacent c-Kit expressing
crest cells. Werhle-Haller & Weston (1995) demonstrated soluble SCF
functions to disperse c-Kil melanoblasts along a dorsolateral pathway,
whereas membrane bound SCF induces migration from the neural crest to the
dermis. Subsequently, SCF is expressed in the mesenchyme of embryonic skin
during the period in which c-Kil melanoblasts migrate from the neural crest
toward the dermis (Matsui et al., 1990; Manova & Bachvarova, 1991; Werle
haller & Weston, 199 5).
Nishikawa et al (1991) and Yoshida et al (1996) demonstrated that stages
of melanoblast migration and proliferation require c-Kit expression.
Specifically, entry into and proliferation within the epidermis is dependent
upon c-Kit expression; this is in contrast to a period just prior to epidermal
invasion, when melanoblasts are dormant in the dermis and c-Kit negative.
SCF /c-Kit signalling is also required in the development of the hair
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follicle pigmentary unit. Before the onset of hair follicle morphogenesis, in
perinatal mice, c-Kit expressing melanoblasts are seen migrating into the
developing hair placode where widespread epithelial SCF expression exists
(Peters et al., 2002).

Thus it is apparent that c-Kit expression plays an

important role in the temporal regulation of melanoblast proliferation and
migration.

2.5.2 Alterations of c-Kit Signaling Pathways
Murine transgenic studies and mutational analyses of c-Kit have shown
that this gene is crucial for melanocyte development since this gene affects the
functional role of the encoded tyrosine receptor (Nishikawa, 1991; Galli et al.,
1993; Grabbe et al., 1994; Broudy, 1997). In humans, mutations in c-KIT result
in piebaldism, a syndrome in which affected individuals possess a white
forelock and absence of pigmentation of the medial portion of the forehead,
eyebrows and chin, chest, abdomen, and extremities. This mutation in c-KIT
leads to substitution of leucine for phenylalanine at codon 584 within the
tyrosine kinase domain of the c-KIT receptor (Giebel & Spritz, 1991).

2.5.3 c-K/Tand CMM
Progression of CMM has been correlated to a loss of c-KIT gene
expression. Increasing loss of the c-KIT receptor has been demonstrated
during the invasive and metastatic phases of CMM and a majority of CMM
cell lines lack detectable levels of c-KIT expression (Lassam et al., 1992; Natali
et al., 1992; Zakut et al., 1993). In a study by Huang et al (1996) transfection of
the c-Kit gene into c-Kit negative CMM cells was shown to inhibit tumour
growth and metastasis in nude mice.
There are several grounds to investigate influence of PAXJ on c-KIT
expression, the most notable being that the promotor region of the c-KIT gene
possesses several potential DNA binding sites for the paired and
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homeodomain regions of PAX3 (Figure 2.21 ). No investigation of Pax3
interactions with c-Kit have been undertaken (to date) to discern repercussions
of aberrant Pax3d expression on c-Kit expression in CMM.
1

gagggatgtcttattagtttatcagaatgcatagggaaagctcatctttcttggagtagg

61
121

tcttccaataagtgttcaagccctgggtcttccctcactacaataataaacatacctgct
ctaccctcctcacaaagctgttatcgtgagcatgaaaagacgagtcgctgtggggaagaa

181
241

ctattaacccctatacagatactgttgttgctttccgttcaaggatccaccatgagactg
tgggtaaggcactttctgggcagtgaaatcgggcttaagagaatcattgtacttttattt

301

tgctcctgggaccggcaagggcagttaagagccctagccctaaaactgtcgtctgttaca

361
42 1
481

gaggcagagaaatcattactggggttggcagcgttggggggaggggggaaaacgtgtatg
aaaacctgggctcccagagcaaacttcgccacgcgccctccatcgcccctgtctccacac
aagtcccggcaggggcttcttgggcggaggccacgccgaccaataggaacccactgtgtt

541
601

cctacaggttacgaagcaggtggagaaattgagcagaaacaattagcgaaaccgggctca
gcctttaccgcggtgccaggagctcctaacaggcctggaggggaatgtcggggctcaatt

661
721
781
841
901
961

tcctaacgctcccctccccatccccatgccacctccacgagcagcggcgtccagcctcct
cccgcccgaacgtgctcgaggggcgggcagtcgacctttattgtctggggagcacctggc
aggtggcgggcccgtgccctaacgtgtgcgtggtgcccagcttcacaaagcgagcgggca
gcacctccttggtccgggaacgcctcagcctggccgtccacatcccaggggtggaaaggt
ggagagagaaaggggctccggagtcaagagcggggagagagggcgcgcgccctcctcctc
ccggcgggcacagccccccggcattaacacgtcgaaagagcaggggccagacgccgccgg

1 021 gaagaagcgagacccgggcgggcgcgagggaggggaggcgaggaggggcgtggccggcgc
1 081 gcagagggagggcgctgggaggaggggctgctgctcgccgctcgcggctctgggggctcg
1 1 41 gctttgccgcgctcgctgcacttgggcgagagctggaacgtggaccagagctcggatccc
1 201 atcgcagctaccgcgatgagaggcgctcgcggcgcctgggattttctctgcgttctgctc
1 261 ctactgcttcgcgtccagacaggtgggacacgcggctggcaccccg

Figure 2.21. Promotor region of c-KIT.
Potential PAX3 binding motifs indicated in red.

Potential PAX3 binding sites, as well as lack of previous co-expression
studies, overlapping temporal expression in embryogenesis and similarity of
functional roles in melanocytic development prompted investigation into
possible co-relations between c-Kit and Pax3 expression in this study.
Furthermore, c-Kit expression is downregulated in CMM (Huang et aL, 1 996
and 1 998) while Pax3 is a known gene repressor (Chalepakis et aL, 1 994).
Therefore, we hyp othesised that overexpression of PAX3 in CMM may
inhibit c-KIT expression, therefore a negative correlation between these genes
was assessed in melanogenesis.
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2.5.4 The MITFGene
Micropthalmia-associated transcription factor (MITF) is a basic helix
loop-helix transcription factor known to function both in the early survival of
melanoblasts (Homyak et al., 2001) and subsequently in regulation of genes
required for synthesis of enzymes involved in melanogenesis (Bentley et al.,
1994; Ganss et al., 1994; Yasumoto et al., 1994; Tachibana et al., 1996).
Furthermore, MITF regulates expression of a melanocortin-1 receptor, a
receptor involved in determining relative proportions of pheomelanin and
eumelanin production (Aoki & Moro, 2002) .

MI1F expression is one of the earliest markers of melanocyte
differentiation and crucial for melanoblast survival during migration from the
neural crest (Opdecamp et al., 1997). Studies of strict temporal regulation of
MITF activity and expression levels during melanocytic development suggest
that MI1F expression cooperates with many factors working coordinately to
regulate differentiation of the neural crest cell through melanoblast stages on
through further differentiation until capable of melanin production (Beerman
et al., 1992; Ferguuson & Kidson, 1997; Nakayama et al., 1997; Opdecamp et
al., 1997) .

2.5.5 MITFMutations
Mutations in the MI1F gene result in Waardenburg Syndrome type Ila
(Tassabehji et a!, 1994), Tietz Syndrome (a hyp opigmentation albinism with
sensorineural deafness) (Smith et al., 2000) or ocular albinism with
sensorineural deafness (Morell et al., 1997). Phenotypes of persons in these
affected families reveal severe congenital sensorineural hearing loss,
hyp opigm entation of follicular melanocytes causing blonde hair to tum grey
during adolescence, pale skin with numerous orange freckles and blue eyes
lacking retinal pigm entation. Similarly, in mice, mutations in Miif lead to loss
of pigm entation in the eye, inner ear, and skin, and to reduced eye size and
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early-onset deafness (Hodgkinson et al., 1993; Nakayama et al., 1998).
MITF, like PAX3, produces alternate isoforms which are constitutively
expressed in various tissues. The neural crest-derived melanocyte specific
isoform is MITF-M (Yajima et al., 1999), the predominant isoform in heart
and kidney is MITF-H (Steingrimsson et al., 1994) and in retinal pigmented
epithelial cells it is MITF-A (Amae et al., 1998). Both the antibodies used for
immunohistochemical staining and primers designed to amplify RT-PCR
products in this study were specific for the melanocyte-specific isoform of
protein or transcript, respectively.

2.5.6 MITFand PAX1
Pax3 has been shown to bind to the promoter and transactivate the
Mitfm gene (Watanabe et al., 1998). As stated previously, Pax3, along with
Sox10 have been implicated as having important synergistic effects on
upregulation of Mitfm expression levels (Bondurand et al., 2000; Potter£ et al,
2000). Mutations in PAX3 result in generation of protein transcription factors
unable to regulate transcription of MITF-M; the phenotype of Waardenburg
Syndrome type I, characterised by pigmentary disorders and hearing loss,
reflects this. Similarly, Splotch mice bearing Pax3 mutations (leading to a
nonfunctional Pax3 protein unable to bind to Mitfm) demonstrates the
dependence of Mitfm on functional Pax3 transcription factors for normal
expression. The activation of Miifby Pax3 initiates a cascade of genes within a
genetic hierarchy that brings about differentiation of the melanocytic cell.

2.5.7 MITFand c-KIT
There is some controversy over the rank of both c-KIT and MITF in the
genetic hierarchy of melanocytic specific genes. Evidence supports a feedback
loop in which MITF regulates c-KIT expression/ activity and c-KIT signaling
regulates MITF expression/ activity. The c-KIT promoter contains an E-box
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motif for MITF binding and in vitro analysis has shown that MITF is able to
activate c-KI.T transcription in cultured cells (Tsujimura et al., 1996). Moreover,
Opdecamp (1997) has demonstrated that MITF is required for upregulation
of c-KI.T expression.
Further studies confirm a feedback loop since c-KIT signaling increases
MITF phosphorylation leading to stimulation of MITF transcriptional activity
(Hemesath et al., 1998; Price et al., 1998; Wu et al., 2000; Xu et al., 2000).
Finally, mice doubly heterozygous for mutations in both c-FJt and Miifhave a
more severe phenotype than mice heterozygous for either mutation alone
(Beechey & Harrison, 1994). These and previously mentioned studies suggest
an interesting interplay between Pax3, c-FJt and Miif expression and
experiments in this study aim to confirm whether co-relations in their gene
expression do exist in murine embryogenesis and melanogenesis.

2.6 CONCLUSION OF LITERATURE REVIE"W' ------It is not unlikely that developmental genetic programs regulating cell
properties may be reactivated in the neoplastic cell. The ability of the
melanoblast to migrate, proliferate and differentiate is vital, whether in
embryogenesis or postnatal re-pigmentation processes. We hypothesise that
the particular properties of the melanoblastic cell that enable it to undergo
these events in both embryonic and postnatal tissue may be conferred through
expression of PAXJ, a gene strongly associated with development of
melanocytic precursor cells. Thus the high, aberrant expression levels of

PAXJ, consistently observed in CMM, may be directly linked to the
progression of CMM.
Clinical research and animal studies have shown that tumourigenesis is
an event reflecting the properties of both host tissues and the neoplastic cell
itself. The ability of a cancer cell to take advantage of genetic programs set in
place specifically for normal cellular events such as cell proliferation,
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migration and sign aling could give the neoplastic cell a tremendous selective
advantage and therefore enhance both its chance of survival and its ability to
evade body defenses. In this study, experimentation sought to provide
information regarding a possible role for PAX3 in the tumourigenesis of
CMM, in light of important genetic events its encoded transcription factors
regulate during normal melanocyte development.
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3

HYPOTHESES
& RESEARCH AIMS

49

3.1 HYPOTHESES---------------• The PAXJD transcription factor (predominantly expressed in CMM) is
not a cryptic splice form, but rather, is utilised during the development
of normal melanocytes.
• Aberrant expression of PAXJD contributes to the progression of
CMM through transactivation of MITF-M and/ or repression of c-KI.T
genes.

3.2 RESEARCH AIM.._,_________________
• Compare relative mRNA expression of PAXJC/PAXJD in cutaneous
melanoma biopsies using mRNA isolation, RT-PCR and nucleic acid
sequencmg.
• Investigate and compare relative mRNA expression of Pax3c/ Pax3d at
key stages of murine embryonic development using mRNA isolation,
RT-PCR and nucleic acid sequencing.
• Investigate and compare relative mRNA expression of Pax3c/Pax3d in
an in vivo model of murine melanogenesis using mRNA isolation, RT
PCR and nucleic acid sequencing.
• Assess spatial and temporal Pax3c/Pax3d protein expression m
developing murine embryos at key stages of melanocytic development
by immunohistochemistry.
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4

METHODS
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4.1 PAX3TRANSCRIPT ANALYSISIN CMM
4.1.1 Human Tissue Collection
Five metastatic CMM excised from regional lymph nodes were acquired
through Clinical Professor Dominic Spagnolo of PathCentre (Perth, WA).
Following patient consent, samples were snap-frozen in liquid nitrogen
immediately following surgical excision and stored at -70 ° until use, according
to PathCentre protocol for acquisition and storage of tissue samples for
research use. Subsequent collaboration with surgeons allowed samples to be
retrieved from tissue archives; ethical clearance for use of the human tissues
was acquired through the Human Ethics Committee of Edith Cowan
University (project #02-68).

4.1.2 Isolation of Total RNA
Total RNA was isolated from samples usmg TriZol Reagent
(Invitrogen). Tissues were homogenised in l mL of TriZol per 50-100 mg of
tissue using a glass-col homogeniser. Homogenised samples were incubated at
15 ° -30 ° for 5 minutes. 0.2mL of chloroform was added followed by 3 minutes
incubation at 15 ° -30 °. Samples were centrifuged at 12000rpm for 15 minutes
at 2 ° -8° to isolate the RNA into the aqueous phase of the solution. RNA was
precipitated from the aqueous phase by addition of 0.5 mL of isopropyl
alcohol, incubation for 10 minutes at 15° -30° and centrifuged at 12000rpm at
2 ° -8° for 10 minutes. RNA precipitates were washed with 1 mL 7 5% ethanol,
centrifuged at 7500rpm at 2 ° -8° for 5 minutes and briefly air-dried for 10
minutes. RNA was redissolved in 0.4 mL RNase free water and incubated at
60 ° for 10 minutes. Integrity of the total RNA extracted from the samples was
assessed by 1 % agarose-gel electrophoresis and ethidium bromide stained
visualisation of the gel under UV light..
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4.1.3 PolyA+ mRNA Purification
An Oligotex mRNA kit (Qiagen) was utilised according to the
manufacturer's instructions. Briefly, mRNA, containing polyadenylated tails
was isolated from total RNA by hybridisation of the polyA+ tail to a dT
oligomer coupled to a solid-phase matrix. Following separation of the
mRNA:Oligotex complex, poly A+ mRNA was eluted from the matrix using
120µL SmM Tris-Cl (pH 7.5) and stored at -70° C until further use.

4.1.4 RT-PCR Analysis of PAX3C/PAX3llfranscripts
Negative controls for each polyA+ sample were performed by
elimination of the reverse transcription portion of reverse transcription
polym erase chain reaction (RT-PCR) . RT-PCR products were assessed by 2%
agarose-gel electrophoresis and ethidium bromide staining. PolyA+ mRNA
was converted to cDNA using the One-Step RT-PCR Kit (Qiagen) according
to the following protocols:

Component

Volume

RN ase free water

7.0µL

Sx Qiagen OneStep RT-PCR Buffer

5.0µL

dNTP Mix (containing 10mM of each dNTP)

1.0µL

Sx Q solution (Qiagen)

5.0µL

Forward Primer (0.6µM)

1.SµL

Reverse Primer (0.6µM)

1.SµL

Qiagen One-Step RT-PCR Enzyme Mix

1.0µL

Template mRNA (1 pg-2µg/ reaction)

3.0µL
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The following primers were designed prior to manufacture by Geneworks
Pty Ltd. for RT-PCR of PAX3C and PAX3D from CMM samples:
• PAX3C (FWD) 5' gcaatttctcctggaaggga 3'
• PAX3C (REV) 5' attgataccggcatgtgtgg 3'
• PAX3D (FWD) 5' tgggcagtatggacaaagtg 3'
• PAX3D (REV) 5' ggctgcgaagaccagaaac 3'

RT-PCR cycling conditions were as follows:

C�cle

Time

Temperature

Reverse transcription

30 min

50°C

Initial PCR activation step

15min

95°c

Denaturation

30 sec

9 4°c

Annealing

15 sec

56°C

Extension

15 sec

12°c

10min

12°c

3-step cycling:

Number of cycles: 40
Final extension

Negative controls eliminating template mRNA were included in each
RT-PCR assay. RT-PCR products were analysed by 2 °/o agarose-gel
electrophoresis and ethidium bromide staining relative to pUC 19 DNA
ladder. Gels were run at 1 10 mV for 30 minutes in TAE buffer.
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4.1.5 Sequencing Reactions
Using the MinElute PCR Purification Kit (Qiagen) according to
manufacturer's instructions, 200mL Buffer PB was added to 40µL of PCR
sample and loaded into a MinElute spin-column prior to centrifugation at
13000 rpm for 1 minute. Following DNA binding to the spin-column matrix,
flow-through was discarded prior to addition of 750 mL Buffer PE to the
spin-column and further centrifugation at 13000 rpm for 1 minute. Flow
through was again discarded prior to centrifugation for an additional 1 minute.
DNA was eluted by addition of 10 mL Buffer EB to centre of MinElute
membrane, stood at room temperature for 1 minute prior to centrifugation at
13000 rpm for 1 minute. This purification method removed all PCR reagents
and DNA fragments under 70 base-pairs long. The ABI PRISM BigDye
Terminator Cycle Sequencing Ready Reaction Kit (PE Biosystems) was used
to prepare and analyse sequence amplicons by the dideoxy sequencing
method. Sequencing reactions were run using the following protocol:

DNA (approx. 100bp)

4µL (10ng)

Primer (Fwd or Rev)

1µL (50 ng)

Big Dye Terminator Mix

4µL

ddH20

1µL

Sequencing cycling conditions were as follows:
96° C------ 10 sec.
50° C------ 5 sec.
60° C------ 4 min. Repeat for 25 cycles.
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For removal of excess dye terminators pnor to sequencmg,
ethanol/sodium acetate precipitation of DNA was done by addition of 2.0 rnL
3M sodium acetate (pH 4.6) and 50rnL 95% ethanol to each completed
sequencing reaction. Tubes were shaken, left at room temperature for 5
minutes then centrifuged at 1 3000 rpm for 45 minutes. Supernatant was
discarded before addition of 150rnL 70% ethanol and centrifugation at 13000
rpm for 10 minutes. Supernatant was again discarded and 150 µL of 70%
ethanol added to each pellet prior to centrifugation at 13000 rpm for 10
minutes. Supernatants were discarded and pellets dried at 65° C. Products
were sequenced by the DNA sequencing services at Royal Perth Hospital
(Perth) using an ABI Prism 3730 48 capillary sequencer; sequences were
aligned with known sequences in GenBank using the multi.align tool in the
Angis computer program, available on GenBank.

4.2 MURINE EMBRYO TRANSCRIPT ANALYSIS-----4.2.1 Collection of murine embryonic samples
Wild-type ARC outbred mice were housed 1n community cages at
Edith Cowan University, fed water and murine chow ad libitum and kept in 1 2
hour light and dark cycles. Pregnant female mice and embryos were
euthanised by CO2 overdose in a sealed container. Pregnancies and embryonic
ages were timed by sight of the vaginal plug and embryos were surgically
removed at embryonic day 1 1 (El l), E1 2.5, E1 5 and E20.
Whole embryos were used to analyse Pax3 transcripts at El 1 , the time
of migration of melanoblasts from neural crest to the dermis. At E1 2.5, there
is synchronous migration of melanoblasts from the dermis to the epidermis.
Skin could not be dissected from the embryo at this time, however, to analyse
Pax3 transcripts, segregation of head from body of E12.5 embryos was used
to analyse Pax3 transcripts of the developing limb, trunk and diaphragm
musculature as compared to Pax3 transcripts of the brain. Tissues isolated
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from E15 and E20 embryos included whole skin, body Oess skin) and head
Oess skin) . Skin was segregated, in particular, to examine Pax3 transcripts
during the E15 stage of melanoblast migration into the developing hair
placode and the E20 stage of differentiation of the melanoblast toward the
melanin producing melanocyte. All murine embryonic tissue specimens for
mRNA analyses were immediately snap-frozen in liquid nitrogen following
excision and kept frozen at -70° until use. Ethical clearance for use of the
animals was acquired through the Animal Ethics Committee of Edith Cowan
University (project # 03-A8).

4.2.2 Total RNA and polyA+ mRNA Isolation
Total RNA isolation and polyA+ mRNA purification from munne
embryonic samples was performed as detailed in sections 4. 1 .2 and 4. 1 . 3.

4.2.3 RT-PCR Analysis of Pax3c/3dTranscripts
Protocols for RT-PCR assays were as detailed in section 4.1.4. The
following primers were designed for RT-PCR of Pax3c/ 3d from murine
embryonic samples:
• Pax3c (FWD) 5' gggggtagttcctcctgg 3'
• Pax3c (REV) 5' caatcagctgtctttgccac 3'
• Pax3d (FWD) 5' tgggcagtatggacaaagtg 3'
• Pax3d (REV) 5' gtggaggccggaaacagg 3'
These primers were manufactured by Geneworks Pty Ltd., Australia.

4.2.4 RT-PCR Analysis of c-KitTranscripts
PolyA+ mRNA was converted to cDNA using the protocol described
1n 4.1.4. The following primers were designed for RT-PCR of c-Kit from
murine embryonic samples:
• mcKitF (FWD) 5' agacagacaagaggagatc 3'
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• mcKitR (REV) 5' aatacaattcttggaggcga 3'
These primers were manufactured by Geneworks Pty Ltd., Australia.

RT-PCR cycling conditions were as follows:

Cicle

Time

Temperature

Reverse transcription

30 min

50°C

Initial PCR activation step

15min

95°c

Denaturation

30 sec

94°C

Annealing

15 sec

52° c

Extension

15 sec

12°c

10min

12°c

3-step cycling:

Number of cycles: 40
Final extension

Negative controls eliminating template mRNA were included in each RT
PCR

assay.

RT-PCR

products

were

analysed

by

2%

agarose-gel

electrophoresis and ethidium bromide staining relative to pUC19 DNA
ladder; gels were run at 110 mV for 30 minutes in TAE buffer.

4.2.5 RT-PCR Analysis of Mitf-m Transcripts
PolyA+ mRNA was converted to cDNA using the protocol described
in 4.1.4. The following primers were design ed for RT-PCR of Mitfm from
murine embryonic samples:
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• mA1ITFF (FWD) 5' taagtggtctgcggtgtc 3'
• mA1ITFR (REV) 5' atgcctctttttcacagttg 3'
These primers were manufactured by Geneworks Pty Ltd., Australia.

RT-PCR cycling conditions were as follows:

Cicle

Time

Temperature

Reverse transcription

30 min

50°C

Initial PCR activation step

15min

95°c

Denaturation

30 sec

94°c

Annealing

15 sec

54°c

Extension

15 sec

72 °c

10min

72 °c

3-step cycling:

Number of cycles: 40
Final extension

Negative controls eliminating template mRNA were included in each RT
PCR

assay.

RT-PCR

products

were

analysed

by

2 °/o

agarose-gel

electrophoresis and ethidium bromide staining relative to pUC 19 DNA
ladder; gels were run at 1 10 mV for 30 minutes in TAE buffer.
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4.3 MORINE FOLLICULAR TRANSCRIPT ANALYSIS
�---To assess the expression of Pax3c and Pax3d in murine melanoblastic
cells during proliferation and migration throughout normal hair follicle re
pigmentation, active synchronised hair growth (anagen) was induced in mice
by depilation. Methods were based on those previously described by Paus et al
(1999) as these are recognised methods used to assess gene expression during
murine hair regrowth.

4.3.1 Collection of Murine Skin Samples
Wild-type C57BL/ 6 inbred mice were housed in community cages at
. Edith Cowan University, fed water and murine chow ad libitum and kept in 12
hr light/dark cycles. Mice were sedated with midazolam (Hyponovel, Roche)
via intramuscular injection at a dosage of 0.1mg/kg. Using a wax/rosin
mixture warmed to 38 ° , a 15x15mm area of skin was depilated at the cervical
region of the back. At 12, 24, 36, 48 and 60 hours post depilation, mice were
euthanised by CO2 overdose and skin samples harvested. Skin was thoroughly
cleansed with 100% ethanol prior to being immediately snap-frozen in liquid
nitrogen and kept at -70° until use. Ethical clearance for depilation and use of
the animals was acquired through the Animal Ethics Committee of Edith
Cowan University (project # 03-A8) .

4.3.2 Isolation of Total RNA-Murine Skin Samples
Frozen skin samples were crushed with liquid nitrogen in a mortar and
pestle prior to addition to TriZol Reagent (Invitrogen). Crushed tissues were
homogenised in 1mL of TriZol per 50-100 mg of tissue using a glass-col
homogeniser. Homogenised samples were passed several times through a 19
gauge needle with syringe prior to addition of 1 OµL proteinase K solution
(10mg/mL ddH20). Solution sat at room temperature for 10 minutes prior to
continuation of isolation procedure as described in section 4.1.2.
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4.3.3 PolyA+ mRNA Purification
PolyA + mRNA purification of 10 murine skin samples was performed
using protocol detailed in section 4.1.3.

4.3.4 RT-PCR Analysis of Pax3c/3dTranscripts
RT-PCR of 10 murine skin samples for Pax3c/ Jd was performed using
protocol detailed in section 4.2.3.

4.3.5 RT-PCR Analysis of c-KitTranscripts
RT-PCR of 10 murine skin samples for c-Kit was performed using
protocol detailed in section 4.2.4.

4.3.6 RT-PCR Analysis of Mitf-m Transcripts
RT-PCR of 10 murine skin samples for Mitf-m was performed using
protocol detailed in section 4.2.5.
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4.4 IMMUNOHISTOCHEMISTRY ANALYSES ------4.4.1 Pax3 Protein Analysis in Murine Embryogenesis
Following surgical excision, embryos were immersed m OCT and
frozen immediately in thawing isopentene. These were stored at -70 °C until
further use. Frozen murine embryos were cryosectioned into 6 µm tissue
sections at -20°C onto Superfrost Plus slides and immediately taken through
the staining protocol as follows.
Sections were air-dried for six hours prior to immersion in acetone at
4 °C for 1 minute and allowed to stand at room temperature for 1 minute.
Sections were rehydrated in Tris buffered saline for 5 minutes prior to
incubation in phosphate buffered saline (PBS) and Triton-X100 (0.2%) for 10
minutes. Sections were then incubated in PBS containing 3% H20 2 for 10
minutes. Sections were rinsed in fresh PBS 2 times for 7.5 minutes prior to
incubation for 30 minutes with PBS and 10% fetal calf serum. PBS/10%fetal
calf serum was poured off sections prior to incubation with Pax3c or Pax3d
antibodies. These rabbit polyclonal antibodies were manufactured and kindly
donated by Tom Barber and Johns Hopkins University; sequences of C
terminus amino acids used for their manufacture are kpwtf for Pax3c and
afhylkpdia for Pax3d. These primary antibodies were applied at a 1:10 working
dilution prior to standing overnight at 4°C.
Sections were washed in fresh PBS 2 times for 15 minutes followed by
incubation of secondary antibody consisting of biotinylated anti-rabbit IgG
(DAKO LSAB2 System) for 10 minutes at room temperature. Sections were
washed in PBS for 15 minutes prior to application of tertiary antibody
consisting of horseradish peroxidase (HRP) linked streptavidin (DAKO
LSAB2 System) for 10 minutes at room temperature. Following a wash in
PBS for 15 minutes, the staining reactions were completed using 3, 3diaminobenzidine (DAB) substrate (Sigm a Chemicals) as chromogen. Sections
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were incubated with DAB for 2 minutes, placed in ddH20 to stop reaction
and taken through an ethanol and xylene series (70/95/100/100/100/3X
xylene) prior to coverslipping with DEPEX mounting medium (EMS) .
Negative controls consisted of sections processed at the same time and in the
same manner, however primary antibodies were eliminated.
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5

RESULTS
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"Science knows ofinstances where an investigator was in possession ofall the important facts
yet failed to ask the right questions. "
Emst Mayr

5.1 mRNA ANALYSES ---------------5.1.1 PAX3 mRNA in CMM
Aberrant expression of PAXJ in CMM was first detected by Barr et al.
(1999), who found that expression levels were "notably high"; moreover, they
described the predominant P AX3d transcript as a novel transcript. In a similar
study, Scholl et al. (2001) reported that 77% of melanomas tested showed

PAX3 expression while all normal perilesional skin, melanocytes and benign
lesions tested showed no PAXJ expression. In order to analyse the relative
expression profiles of PAX3 in CMM, metastatic CMM samples (cytologic
diagnosis following excision confirmed

using Giemsa

staining and

immunohistochemistry) were assayed for PAXJC and PAXJD mRNA.
Total RNA was isolated from each sample, prior to isolation of
polyadenylated (polyA; mRNA. PolyA+ isolation of mRNA was necessary to
ensure that products generated by RT-PCR were from mRNA rather than
from genomic DNA as differential amplification of PAXJC from PAXJD
utilises a 3' primer corresponding to a retained intronic sequence within the

PAXJC sequence. Negative controls for each sample were performed by
elimination of the reverse transcription portion of the RT-PCR reaction.
Each sample was then analysed for both PAXJC and PAXJD transcripts by
RT-PCR to provide a relative expression profile of these transcripts within
each sample. Controls and RT-PCR products were then analysed and
visualised by 2% agarose gel electrophoresis.
In the CMM biopsies tested, 100% (5/5) showed both PAXJC and

PAXJD expression, as was expected (Figure 5.1).
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-89 bp

-104 bp

5.1.2 Pax3 mRNA in Murine Embryogenesis
To date, no published studies have
PAX3D/Pax3d

in

normal

human

or

identified expression of

mouse

melanocytic

tissues.

Consequently, a primary aim of the study was to investigate whether the
Pax3d transcript is expressed during normal melanocytic development. Pax3 is
known to alter transactivational function through alternative splicing of the 3'
end, so it was queried whether Pax3d may be primarily utilised by muscle or
brain cells with expression in CMM being uncharacteristic for melanocytic
cells. Therefore, murine embryonic tissues were separately analysed as brain,
trunk and limb skeletal muscle (herein referred to as boqy samples) and skin
samples (where possible) to identify specific localisation of Pax3 mRNA
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expression within brain, limb bud and skin cells; embryonic age was chosen to
reflect key stages of melanocytic development. Samples are outlined in Table
6.
Table 4. Sample selection for investigation of PaxJc and Pax3d transcript
expression in murine embryogenesis.

�

N:umber Qf samples

Tiss:ue se�tiQns

Embryonic day 11 (E11): Melanoblasts

one

whole

six

head, body

nine

head, body, skin

nine

head, body, skin

migrate from neural crest to dermis (Mayer,
1 973)
E12.5: Melanoblasts synchronously migrate
from dermis into epidermis (Yoshida et al.,
1 996)
E15: Melanoblasts migrate into hair follicles
(Hirobe, 1 984)
E20: Visible melanin formation indicates
melanocytic differentiation (Miiller-Rover et

al., 2001)

Thus, a total of 25 murine embryonic samples were assayed for Pax3c
and Pax3d expression. Total RNA was isolated from samples prior to isolation
of polyA+ mRNA. Again, polyA+ isolation of mRNA was necessary as
differential amplification of Pax3c from Pax3d utilises a 3' primer
corresponding to a retained intronic sequence. Negative controls for each
sample were performed by elimination of the reverse transcription portion of
a RT-PCR prior to visualisation by 2% agarose gel electrophoresis. Each
sample was then analysed for both Pax3c and Pax3d transcripts by RT-PCR
and visualised by 2% agarose gel electrophoresis (this method of analysis
provides a relative expression profile of these transcripts within each sample).
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At E11 , both Pax3c and Pax3d transcripts are expressed (Figure 5.2) . At
this stage, whole embryos were used because it was merely necessary to show
the presence or absence of Pax3c or Pax3d; consequently, while the Pax3d
transcript is expressed, lineage (s) activity at this developmental stage remains
undetermined.

117 bp
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At E12.5, both Pax3c and Pax3d transcripts are expressed in the head
and body (Figure 5.3). Segregation of the skin from these embryos was
unsuccessful as it was fragile and thin; therefore, Pax3c and Pax3d expression
may be indicative of transcriptional activity in neural, muscle and/ or
melanocytic lineages at this stage. It suffices to say that both transcripts are
expressed at this stage of murine embryogenesis and that Pax3d is a
functioning transcript.

Figure S..1. Detection of Pax:Jc, P.add'Tramcripta in E12.5 Murlne Einbtyos.
RT-PCR products geoei:ated from E12.5 mRNA, using exon 8 (PaxJ" and exon 9 (PaxJd)
p� -,jsualised. on 2% ethidium bromide-stained agarose gels. Pa:Jc= PaxJ, tmnscript amplified
(expectec:l product leogth- 1 1 7 hp); Pax3c#= PaxJd tmnsaipt amplified (expected product length- 97 hp);
hd= heac1; bd= body; -co= negative control for primers without template mRNA; pUC= DNA ladder
(pUC 19 digested with Hpall).
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At E15, all tissue samples showed Pax3c and Pax3d transcript
expression (with the exception of the skin of embryo #2) thus indicating a
role for both transcripts in neural, muscle and melanocytic cells at this stage of
development (Figure 5.4 ).

117
hp

F� 5,4. Detection of Psudc, Pa.ddTransctipta in Et5 Morine Embryo&,
RT-� products generated from B15 � using exon 8 (Pa:d9 and exon 9 (Pa:dd)
� wuilised on 2% etbidium bromide-stained aguose gels. Pa.1t:= PaxJt- ttanscrlpt amplified
(� � �- 1 1 7 bp); Pax.1d=: PaxJd ttansctipt amplified (expected product length- 97 bp);
hd=head; bd=body; ak;:skin; -co = neg-ative conuol fot prlmets without template mRNA; pUC = DNA
laddet (pUC 19 digested with Hpall).
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By E20, Pax3c transcript expression 1s evident m all, while skin
primarily lacks Pax3d expression (Figure 5.5).

PaddTramcripta in E20 Mudne Embryos.

ted from E20 �A, using exon 8 (Pt«J9 and exon 9 (Pt«Jd) primers,
· c-stained agarose geli. Pax.1t::;:. PIIXJ( tl:aQ&aipt amplified (expected
PaxJd transaipt a.mi,lified (expected product length- 97 bp); hd=head;
•
control for primers without template mRNA; pUC=DNA laddet (pUC

In summary, the Pax3d transcript is found expressed in normal murine
embryogenesis at key stages of melanocytic development. Moreover, both
Pax3c and Pax3d transcripts are expressed in various segregated tissue samples
chosen to reflect brain, muscle and skin lineages.
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5.1.3 Pax3 mRNA in Follicular Regrowth
As the hair follicle cycles through stages of growth, regression, resting
and shedding, pigment cells also cycle through periods of proliferation,
migration, differentiation and apoptosis (Milller-Rover et al., 2001). Histologic
and ultrastructural studies have demonstrated that when the hair follicle
undergoes active growth (anagen), melanoblasts migrate out of a stem cell
niche, proliferate, localise in the hair matrix before further proliferation and
differentiation into mature melanocytes (Nishimura et al., 2002).
In order to induce spontaneous anagen, depilation of C57 /BL6
pigmented mice was carried out according to standard methods (Paus et al.,
1999). Subsequent hair growth was exploited to analyse Pax3 expression, in
particular, to investigate generation of Pax3d transcripts in an additional
"normal" melanocytic proliferation, migration and differentiation model. Skin
samples were taken every 1 2 hours up to 60 hours post depilation,
corresponding to proliferation and migration of melanoblasts into the
regenerating hair placode during anagen. Two separate depilation experiments
were performed using one mouse for each stage of 1 2 hour analysis, therefore
providing a total of 10 skin samples for analysis of Pax3c and Pax3d
expression. Prior to isolation of mRNA from the depilated skin samples,
haematoxylin and eosin staining was performed on adjacent sections of
depilated skin to ensure complete removal of hair sheath and associated
melanocytes of the inner root sheath.
Total RNA was isolated from each sample, prior to isolation of polyA+
mRNA. To ensure genomic DNA was not present in the isolated mRNA
samples, negative controls for each sample were performed by elimination of
the reverse transcription portion of a RT-PCR reaction. RT-PCR products
were assessed by 2% agarose gel electrophoresis. Each sample was analysed
for both Pax3c and Pax3d transcripts by RT-PCR, providing a relative
expression profile of these transcripts within each sample.
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In depilation experiment #1, individual samples were taken at 12-hour
intervals up to 60 hours post depilation. In this trial, Pax3c expression was
seen at 24, 36, 48 and 60 hours post depilation .. By contrast, Pax3d expression
was only observed at 12 hours and then at 48 hours post depilation (Figu re
5.6).

- 1 1 7 bp

-97 bp

Pigtue 5.G. Detection of Pax.Jc, Pa.ddTranactipta in Depilation Experiment #1
RT-PCR products generated ftom depilated skin mRNA samples, using exon 8 (PaxJf) and exon 9
(PaxJt!J prunen, visualised on 2% ethidium bromide-stained agatose gels. Pax.1c= PaxJe ttanscript
amplified (expected product length- 1 1 7 bp); Pax.'Jd= PaxJd ttanscript amplified (expected product length97 bp); 12, 24, 36, 48, 60 indicates 12 hour time interval ftom depilatlon; -co= negative control for primers
without template mRNA; pUC=DNA ladder (pUC 19 digested with Hpall).
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Depilation experiment #2 confirmed findings of experiment # 1 . Again,
individual samples were again taken every 1 2 hours up until 60 hours post
depilation. As for trial #1, in trial #2 Pax3c expression was seen at 24, 36, 48
and 60 hours post depilation and Pax3d expression was seen first at 1 2 hours
and then at 48 hours post depilation (Figure 5.7).

- 1 1 7 bp

-97 bp

In summary, the depilation experiments reiterated a role for Pax3d in
normal melanocytic development, in this instance when coupled to hair
follicle cycling. The Pax3c transcript was expressed in 8:10 samples assayed;
the Pax3d transcript was expressed in 4: 1 0 samples. As melanin granules
appear above the dermal papilla at approximately 96 hours post depilation
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(Muller-Rover et al., 200 1 ), Pax3c and Pax3d express10n seen

10

these

experiments is indicative of an early role in proliferation, migration and/ or
differentiation of melanoblasts during anagen hair growth. Furthermore,
Pax3d expression is seen within 12 hours post depilation, prior to Pax3c
expression in these experiments.

5.1.4 c-.Kit mRNA in Follicular Regrowth
Both Pax3 and c-Kit are important in melanocytic development, ·therefore,
we tested the hyp othesis that Pax3 may regulate c-Kit. Overlapping spatial and
temporal expression of Pax3 and c-Kit in murine melanogenesis prompted
investigation into possible concurrent expression patterns in hair follicle
cycling. The expression pattern of c-Kit in the early stages of hair follicle
melanogenesis was therefore assessed for correlation with the observed
expression patterns of Pax3 in skin samples from depilation experiments.

1 64 bp-

Figure S.8. Detection of cKitTranscripta in Depilation Experiments.
RT-PCR. products generated from depilated skin mRNA samples, using ,Kit primers, visualised
on 2% cthidium. bromide-stained agarose gels. cKit= ,Kit transcript amplified (expected product length164 bp); 12, 24, 36, 48, 60 indicates 1 2 hour time intervals for depilation; -co= negative control for
primers without template mRNA; pUC=DNA ladder (pUC 1 9 digested with Hpall).
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c-Kit expression was seen 1n 100% (1 0 / 10) of depilated skin samples,
ranging from 12 to 60 hours post-depilation (Figure 5.8) . In both depilation
trials, c-Kit expression is seen at 12 hours post depilation, preceding Pax3c
· expression therefore indicating that c-Kit expression is not related to Pax3c
expression. Consistency of c-Kit expression throughout anagen, as compared
to varied temporal expression of Pax3d, also indicates that c-Kit expression
may not be related to Pax3d expression.

5.1.5 Mitf-m mRNA in Embryogenesis
Another candidate gene thought linked to Pax3(d) transactivation was
micropthalmia-associated transcription factor (MiifJ. Miif is one of the earliest
genes expressed in the melanocytic lineage (Opdecamp et al., 1 997) . Like Pax3,

Miif produces alternative isoforms that are constitutively expressed in various
tissues, the melanocyte specific isoform being Mitf-m (Yajima et al., 1 999) .
Pax3 has been shown to bind and transactivate the promoter region of Mitf-m
(Watanabe et al., 1998), therefore, co-expression studies were undertaken to
investigate a possible association between Pax3 and Mitf-m expression in
embryogenesis. Using primers specific for the Mitf-m isoform, RT-PCR of
murine embryonic mRNA samples (previously tested for Pax3 mRNA) was
performed to analyse Mitf-m mRNA expression.
The results indicate that Mitf-m is initially expressed in the E1 1 embryo,
but is not seen in tissues of the E12.5 embryo. Expression is again apparent in
the skin of E1 5 and E20 embryos (Figures 5.9 and 5.10); like Pax3c and
Pax3d, Mitf-m is observed at most stages of melanocyte development (bar
E1 2.5).
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314 bp-

Pig,ue 5.9. Detection of Mitf.m Transcripts in Morine Emmyoa.
RT-PCR products generated &om Et 1 , E125, E15 and E20 mRN.A. using Mif-111 primen for
melan� specific isofoaa. visualised on 2% ethidium bromide-stained aguose gels. Mitf.m= Mitf-111
ttansaipt amplified (expected product length- 314 bp); hd=bead; bd=body; 1k=skin; -co= negative
control for primen without template mRNA; pUC=DNA ladder (pUC 1 9 digested with Hpall).

314 bp-

Figutt S.10. Detection of Mitf.m Tran1cripta in Morine Embtyo1.
RT-PCR products generated &om El 1, E12.5, E15 and E20 mRNA, using Mitfm primei:s fot
m.elanocytic specific isofonn, visualised on 2% ethidiwn bromide-stained aguose gels. Mitf.m= Mitfm
ttansc:tipt amplified (expected product length- 314 bp); hd=head; bd=body; 1k=skin; -co= negative
control for primers without template mRNA; pUC=DNA ladder (pUC 1 9 digested with Hpall).
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5.1.6 Mitf-m mRNA in Follicular Regrowth
Investigation of potential Pax3 and Mitf-m co-expression patterns was
also undertaken with skin samples from depilation experiments. Using primers
specific for the Mitf-m isoform, RT-PCR of depilated skin mRNA samples
(previously tested for Pax3 mRNA) was performed to analyse Mitf-m mRNA
expression. Results indicate varied expression of Mitf-m in depilation
experiments with expression seen in 50% (5/10) of skin samples assayed. In
both experiments, no Mitf-m is observed at 12 hours past depilation and varied
expression is observed at 24, 36, and 48, hours past -depilation (Figu re 5.11).
Furthermore, Mitf-m is observed at 60 hours in both experiments confirming a
role for Mitf-m in the maintenance of the melanocytic lineage.

314 bp-

Figutt S.1L Detection of Mitf-m Transcripts in Depilation Experiments.
RT-PCR products gcnemted from depilated skin mRNA samples, using Wf-111 primers for
melanoc:ytic specific isofom1, visualised on 2% ethidium bromide-stained ag-arose gels. Mitf-m= M.if-111
tmnscript amplified (expected product length-314 hp); 12, 24, 36, 48, 60 indicates 12 hour time intervals
for depilatlon; -co = neg-ative control for primers without template mRNA; pUC=DNA ladder (pUC 1 9
digested with HpaII).

In summary, RNA expression analyses of Pax3c, Pax3d, c-Kit and Mitf-m
revealed no obvious relationship between c-Kit and Pax3 expression. Mitf-m
expression patterns within murine embryogenesis may be linked to Pax3c
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expression, however further immunohistochemical co-localisation studies are
required to investigate this possibility. The following table summarises Pax3c,
Pax3d, cKit and Mitf-m RNA expression patterns observed throughout murine
stages of embryogenesis and hair follicle cycling (Table 7).

Table 5. Overview of Pax3c, Pax3d, cKit and Mitf-m Expression in Stages of
Murine Embryogenesis.

Pax3d

Mitfm

Expressed

Expressed

E12.5- Melanoblasts synchronously

Expressed in

Not expressed

migrate from dermis into epidermis

head, body

E1 1- Melanoblasts migrate from neural
crest to dermis (Mayer, 1973)

(Yoshida et al., 1 996)
E 1 5- Melanoblasts migrate into hair

Expressed in

Expressed in

follicles (Hirobe, 1984)

head, body, skin

skin

E20- Visible melanin formation indicates

Expressed in

Expressed in

melanocytic differentiation (Milller-Rover

head, body

skin

et al., 2001)
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Table 6. Overview of Pax3c, Pax3d, cKit and Mitf-m Expression in Depilation
Experiments. PD= post depilation.

12 hr PD

Pax3d

Mitfm

Expressed in all

Not expressed

samples
24 hr PD

Not expressed

Expressed in 50%
of samples

36 hr PD

Not expressed

Expressed in 50%
of samples

48 hr PD

60 hr PD

Expressed in all

Expressed in 50%

samples

of samples

Not expressed

Expressed in all
samples
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5.2 Pax3 IMMUNOHISTOCHEMICAL ANALYSE�-----5.2.1 Analysis of E12.5 Pax3 Localisation
Yoshida et al. (1996) demonstrated that around E12.5-13.5,
melanoblasts enter the epidermis synchronously and proliferate extensively.
In order to examine the location of Pax3+ cells in the embryo at this stage,
immunohistochemical staining of E12.5 frozen sections was undertaken using
Pax3c and Pax3d specific antibodies. At the periphery of many sections,
throughout the dermis, positive staining could be seen for Pax3c and Pax3d
proteins, in a pattern typifying migration of melanoblasts from the dermis
toward the epidermis during this window of time (Figure 5.12).

Both Pax3c+ and Pax3d+ cells are most evident in the buccal region,
vibrassal region and dorsal tail regions of the skin at E12.5, differing slightly in
number (Figure 5.13). While Pax3c+ staining was uniform throughout the
entire dermis of the E12.5 sections, Pax3d+ staining was confined to regions
81

of buccal and caudal dermis. Staining results of E12.5 embryos confirm that
Pax3c and Pax3d expression demonstrated in RT-PCR analyses of head and

body samples is linked to a role in melanocytic development at this stage.

Superior lip

B •

..
C
E
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5.2.2 Analysis of Pax3 E15 Localisation
In order to examine the location of Pax3+ cells in the embryo at this
stage, immunohistochemical staining of E 1 5 frozen sections was undertaken
using Pax3c and Pax3d specific antibodies. At around E1 5, a subpopulation of
melanoblasts migrates toward the developing hair germs where they localise in
hair follicle pigm entary units (Hirobe, 1 984) . Analysis of staining within E 1 5
skin sections revealed positive staining for Pax3c and Pax3d proteins at the
periphery of all sections, throughout the epidermis (Figure 5.14). In the skin,
there is a notable variance between Pax3c and Pax3d staining; many Pax3c+
cells are seen within developing hair follicles while few Pax3d+ cells are seen
here. Moreover, Pax3d+ cells are distributed profusely throughout the
epidermis where Pax3c+ cells are sparse. These results confirm RT-PCR
analyses of samples demonstrating both Pax3c and Pax3d expression in
embryos at E1 5; immunohistochemistry, however,

highlights different

expression patterns.
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Furthermore, Pax3c+ and Pax3d+ cell staining 1s seen within the
midbrain of the E 1 5 embryonic sections (Figure 5. 1 5); this is significant in
that ours is the first evidence for a role for the Pax3d transcription factor
within the developing brain.

igure 5.15. Immunhistchemical Staining of Pax3+ Cells in E15 Midbrain.
Immunohistochemical staining of E15 sections using Pax3 primary antibodies and a biotin
atreptavidin-peroxidase system visualised with DAB. Dark brown Pax3c+ (A) and Pax3d+ (B) cells
en in the dorsal layers of the superior collicQ!us as indicated by auows.

Positive staining 1s also seen for both Pax3c and Pax3d in the
panniculus camosus muscle located beneath the subcutis (Figure 5 . 1 4)
explaining evidence for Pax3c and Pax3d expression seen within head and
body samples (less skin) in the RT-PCR analyses.
5.2.3 Analysis of Pax3 E20 Localisation
Murine epidermal melanoblasts begin to terminally differentiate at
around E14, with subsequent pigm entation activity induced 2 days later
(Hirobe, 1 984) . Perinatally, at E20, hair follicles are characterised by initial
melanin formation thus indicating an advanced stage of melanocytic
differentiation. Furthermore, after birth most epidermal melanocytes, except
those of hairless areas such as the ears and tail, undergo apoptosis (Hirobe;
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1 984) leaving only melanoblasts and melanocytes of the hair follicles to
produce pigm entation of the murine coat. Therefore, immunohistochemical
staining of E20 frozen sections was undertaken using Pax3c and Pax3d
specific antibodies in order to compare Pax3 distribution just prior to birth.
In E20 skin, Pax3c+ positive staining is greatly diminished (as compared
to the E1 5 embryonic skin) with only few positive cells along the entire
periphery of the skin. Positive Pax3c staining is primarily seen within the hair
follicle above the dermal papilla and amongst the distal hair follicle epithelium
(Figure 5. 1 6) while no Pax3d+ staining is observed in the skin (Figu re 5.1 7).
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Moreover, in the E20 head, the midbrain shows positive staining for
both Pax3c and Pax3d further supporting a role for Pax3d in development of
the brain (Figure 5.18).

+
In the E20 body, sparse Pax3d cells are seen within the peritoneal

cavity in the region of the ileum while no Pax3c+ cells are seen (results not
shown). Pax3c+ staining is also detected in the nuclei of trunk skeletal muscle
(Figu re 5.19) and within the panniculus camosus muscle located directly
beneath the skin (Figure 5.20) while Pax3d+ cells are not observed in these
regions. The presence of positive cells in the midbrain and within the body
confirms E20 embryonic RT-PCR assays demonstrating Pax3c and Pax3d
expression in head and body (less skin) while immunohistochemical staining
results of the skin highlight differential expression of Pax3c and Pax3d in the
skin and support RT-PCR findings that Pax3c is expressed in murine E20
skin while Pax3d is not expressed.
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In summary, Pax:3 immunohistochemical staining of frozen sections
throughout stages of munne embryogenesis reveals that Pax3d is
constitutively expressed and appears to have distinct spatial and temporal
expression patterns relative to Pax3c. Differences in Pax3c and Pax3d protein
expression seen in our experiments are summarised in Table 9.
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Table 7. Overview of Pax3 Protein Expression in Stages of Murine Embryogenesis.
Pax3cf cells. . .

E12.5

sparsely

distributed

solely

in

buccal,

vibrassal, and tail regions of the dermis.

E1 5

concentrated in the epidermis with almost
no cells within the dermis.
observed in the panniculus camosus.
located in the midbrain.

E20

not apparent in the skin.
sparsely distributed within the peritoneal
cavity in the region of the ilewn.
observed throughout the midbrain.
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6

DISCUSSION
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6.1 Pax3 Expression in Embryogenesis
The impetus for this research originated due to two studies reporting
aberrant PAX3 expression in CMM. In 1999, Scholl et al. reported that PAX3
expression in CMM was "unambiguously confined to tumour cells and not
detected in surrounding normal tissue, normal skin sections, or sections of
benign lesions." Barr et al. (1999) demonstrated that the predominant PAX3
transcript in CMM splices the eighth exon to a "previously uncharacterised
ninth exon" thus sparking a particular interest in the possible relationship of
this alternative transcript to tumourigenesis in CMM.
The first objective became to assess whether the alternative

PAX3D/Pax3d transcript is a cryptic splice form observed only in tumour
cells or a functional transcript utilised in cell development or specification. In
a GenBank search for PAX3 transcripts with alternative 3' ends, two
published expressed sequence tags from a human melanocyte cDNA library
(GenBank H82467 and H97691) were found, implying that two alternate
transcripts are expressed in melanocytic cells. Moreover, a sequence encoding
an identical COOH-terminal to the Pax3d transcript was found in a cloned
quail Pax3 cDNA (GenBank AF000673). The finding of an identical COOH
terminal region encoded by the quail Pax3 gene suggested that the Pax3d 3'
region is conserved. Therefore, a central aim of this research became to
determine the Pax3 transcripts expressed during normal murine melanocytic
development and ascertain evidence of the expression of the alternative Pax3d
transcript during normal murine embryogenesis.
Murine embryos were assayed for both Pax3c and Pax3d mRNA and
protein expression during embryogenesis; in particular, key stages of
melanocytic development were analysed. Embryonic day 1 1 was chosen to
reflect the stage when melanoblasts are known to migrate from the neural
crest. It was not possible to isolate neural crest cells at this stage , however at
E11, Pax3c and Pax3d transcripts are expressed in whole embryo extracts,
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indicating an early role for both transcripts in murme embryogenesis.
Immunohistochemical analysis of Pax3 in embryos at this stage remains to be
analysed.
Embryonic day 12.5 was chosen to investigate Pax3 expression at a
point in murine development when synchronous migration of melanoblasts
from the dermis into the epidermis is known to occur. Segregation of skin
from these embryos was unsuccessful; therefore, mRNA Pax3c and Pax3d
expression noted in the RT-PCR assays of head and body samples alluded to
transcriptional activity in either neural, muscle or melanocytic lineages at this
stage. The immunohistochemical staining for Pax3c and Pax3d proteins,
however, showed clear evidence of their expression within the E12.5 skin;
furthermore, no visible staining was apparent in skeletal muscle and brain. In
the E12.5 sections, Pax3c and Pax3d positive cells are noted in the dermis
patterned in a way resembling streams of cells "migrating" from the dermis
toward the dermal-epidermal border. This pattern of staining was evident
throughout the entire dermis for Pax3c+ cells, while primarily regions of the
mouth, nose and tail showed Pax3d+ cells in the dermis. The results of these
assays are original evidence for the conserved role of the Pax3d transcription
factor as early as embryonic day 1 1 with explicit, yet not exclusive, roles in
murine melanocytic development.
At embryonic day 1 5 melanoblasts are known to migrate from the
epidermis into developing hair follicles. At E15, all segregated tissue samples
(head, body and skin) show Pax3c and Pax3d transcript expression (with the
exception of one sample) thus suggesting a role for both transcripts in neural,
muscle and melanocytic cells at this stage of murine development.
Immunohistochemical staining for Pax3c and Pax3d proteins reveal positive
cells located within the midbrain and panniculus carnosus muscle. These
combined assays are original evidence for the conserved role of the Pax3d
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transcription factor in the development of the brain and panniculus camosus
muscle in murine development.
In the E15 skin, Pax3c+ cells are sparsely distributed in the epidermis
with heavy staining evident within the developing hair follicles. This is in
contrast to Pax3d positive staining which is heavily distributed in the
epidermis with few positive cells seen within developing hair follicles. This
pattern of staining may indicate that Pax3c+ cells localise in the developing
hair follicles prior to Pax3d+ cells, or that cells which successfully migrate to
the developing hair placode subsequently express Pax3c at this stage, while
cells that remain within the epidermis continue to express Pax3d prior to their
migration to the hair follicle. In either case, this seemingly spatial demarcation
between protein expression in melanoblasts at this stage is possibly related to
functional diversity for the two transcription factors.
Perinatally, at embryonic day 20, melanogenesis in the hair bulb has
commenced and melanin synthesis indicates an advanced stage of melanocytic
differentiation. In the E20 mRNA assays, Pax3c expression is again evident in
skin as well as in all the segregated tissue samples indicating a continued role
for the transcription factor in the development of skin, brain and skeletal
muscle at this stage of murine development. Pax3d expression is evident
within the head and body samples, while skin samples lack mRNA expression
at this stage. Immunohistochemical staining for Pax3c and Pax3d proteins
confirm positive cells located in midbrain, thus reconfirming a role for both
isoforms in development of the brain. While Pax3c proteins are evident in
skeletal muscle and panniculus camosus, Pax3d positive cells are evident in
the region of the ileum again supporting a spatial demarcation of protein
expression that may be related to functional diversity. Finally, Pax3c positive
cells are observed in developing hair follicles proximal to the dermal papilla;
whereas, Pax3d positive cells are not stained within the epidermis or hair
follicles. This difference in protein expression between Pax3c and Pax3d
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within the E20 skin further supports the notion of a complex regulaton of
melanocytic development through use of temporally expressed Pax3
alternative transcripts.
Finally, it may be significant that Pax3d expression is not detected
within normal murine melanocytes at and from E20 onwards (unpublished
observations) . These results clearly demonstrate a conserved role for the
Pax3d transcription factor in the earfy development of the melanoblast, prior

to differentiation and the cellular capability for synthesis of melanin.

6.2 Pax3 Expression in Melanogenesis
Demonstration of a conserved role for Pax3d in the early stages of
murine embryonal development prompted further investigation into specific
expression of the isoform during the processes of melanoblast proliferation
and migration during induced hair regrowth. In adult skin, following
depilation, melanocytic stem cells of the hair follicle are known to proliferate,
migrate to a region proximal to the dermal papilla and differentiate in order to
produce melanin for the new hair (Nishimura et aL, 2002). Using a reliable
time-scale for the strict coupling of melanogenesis to active hair regrowth
(anagen), depilation experiments investigated Pax3c and Pax3d expression as
melanoblasts

undergo

anagen

induced

proliferation,

migration

and

differentiation within the hair follicle.
Following depilation, the first melanin pigm ents are visible within 96
hours. Knowing that Pax3d has an early role in the melanoblast, prior to
melanin production, skin assays were conducted every 12 hours past induction
of regrowth to focus on early events of anagen. It should be reiterated that, in
murine skin following successful depilation, the only melanocytic cells
remaining in the skin are those of the follicular stem cell niche; therefore,
analyses of Pax3 expression within the samples gives an indication of mitotic
and post-mitotic melanocytic events in the early stages of melanogenesis.
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In the depilation experiments, Pax3 transcripts exhibit differential
expression patterns during anagen lending further insight into their possible
roles in melanogenesis. For example, Pax3c is initially expressed at 24 hours
and is continuously expressed thereafter (up to 60 hours) while Pax3d is
expressed solely in the period up to 1 2 hours past depilation and within the
3 6-48 hour post depilation period. Using the time-scale of Muller-Rover et al.
(2001), follicular transition from resting state (telogen) to anagen occurs
around 24 hours following depilation. Therefore, expression of Pax3d within
the 12-hour period, much earlier than anagen induction, may indicate a role
for this transcript in the proliferation of stem cells (Nishimura et al., 2002)
within the follicle. It should be noted that depilation induces a short healing
response immediately thereafter; however, mRNA assays of wounded and
healing murine skin do not demonstrate Pax3d expression (unpublished
observations). Furthermore, Pax3d is also expressed within the 36 to 48 hour
post depilation period as the follicle continues through the early stages of
anagen. Again, this controlled temporal expression may be related to a
secondary wave of melanoblast proliferation as progeny cells of the stem cell
population undergo further mitosis (Nishimura et al., 2002) prior to
differentiation into pigmented melanocytes. If Pax3d expression seen in these
experiments is linked to melanoblast proliferation, this could be an important
link to the retention of proliferative capacity in CMM as compared to benign
naevi (which lack Pax3d expression).
An alternate hypothesis may be that observed Pax3d expression is
linked to migration of melanoblasts, initially in the 12 hours post depilation
period as stem cells migrate from the niche prior to mitosis and then again
between 3 6 to 48 hours post depilation as post mitotic cells migrate from the
bulge area toward the dermal papilla. In our murine embryonic mRNA assays,
Pax3d expression is demonstrated at all times of melanoblast migration;
therefore, supporting this hypothesis. If then, Pax3d expression has a role in
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melanoblast migration, this could be an important link to the highly metastatic
capabilities of CMM.
Conversely, in the 12-hour period past depilation, Pax3c expression is
not demonstrated. This lack of expression indicates that Pax3c may not have a
role in the events prior to anagen induction. Moreover, Pax3c expression
directly correlates to the onset of anagen at 24 hours and continues through
anagen until the onset of melanin production. This is not unexpected,
however, as Pax3 is known to regulate genes involved in melanin synthesis,
such as Mitf-m and tyrosinase-related protein-1 (Galibert et al., 1999). Finally,
it should be noted that in the 36 to 48 hour period post depilation, both Pax3c
and Pax3d transcripts are concurrently expressed within the samples. Further
studies are required to investigate concurrent intracellular Pax3c and Pax3d
expression in order to gain insight into possible dosage effects for the two
transcription factors and their individual and specific roles. Such experiments
would include in situ hybridisation with transcript specific probes followed by
CHIP

(Chromosomal

Hybridisation

Immunoprecipitation)

assays

to

determine transcript specific target gene sequences.

6.3 Correlation Studies of Pax3 and c-Kit Expression
Another objective of the research was to link aberrant Pax3c and Pax3d
transcript expression in CMM to regulation of downstream target genes. c-K#
and Miif-m were chosen as potential targets regulated by Pax3c and Pax3d (in
particular) as c-Kit and Miif-m have key roles in melanocytic cell development.
c-Kit became an important candidate for investigation as c-Kit expression is

downregulated in CMM and Pax3 is a known gene repressor. Furthermore,
analysis of the c-Kit promotor element sequence revealed potential binding
sites for Pax3 transcription factors. Finally, mutations in the c-Kit locus of the
mouse result in failure of stem cell populations to migrate and/ or proliferate
effectively due to loss of the tyrosine kinase receptor (Geissler et al., 1988) . As
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our previous experiments had shown an early role for Pax3din melanogenesis,
possibly in proliferation and/ or migration of melanocytic stem cells, the
possibility of aberrant Pax3d downregulation of c-Kit in CMM was proposed
and expression therefore investigated.
mRNA analyses of c-Kit expression in murine embryogenesis was not
undertaken, however, as the c-Kit encoded transmembrane tyrosine kinase
receptor for stem cell factor (SCF) is required for normal hematopoiesis,
melanogenesis, gametogenesis (Geissler et al, 1988) and development of the
smooth musculature of the gastrointestinal tract (Huizinga et aL,1995). Thus
detection of c-Kit mRNA would be expected in all embryonic mRNA assays
and be inconclusive. It was decided, rather, that investigation of c-Kit
expression in the depilation model would provide a more conclusive model
for study of melanogenesis. In the depilation experiments, c-Kit expression is
seen in all time periods, immediately following depilation and throughout
anagen hair regrowth. These results allow us to conclude that c-Kit expression
is not linked to Pax3c expression; its expression both precedes and continues
together with that of Pax3c. Furthermore, c-Kit expression is concurrent with
Pax3d expression early in anagen while loss of Pax3d expression during a 36
hour period in which c-Kit continues to be expressed certainly negates
evidence of c-Kit downregulation by Pax3d These results clearly indicate a
lack of direct correlation between the Pax3 and c-Kit genes in our murine
melanogenesis model and allow us to conclude that aberrant PAX3D
expression does not contribute to the progression of CMM through
repression of the c-KI.T gene.

6.4 Correlation Studies of Pax3 and Mitf-m Expression
It was important to correlate the expression of Pax3 and Miif-m in
melanogenesis as Pax3 is known to synergistically up-regulate Miif-m together
with Sox10 (Potter£ et aL, 2000). In the embryonic mRNA assays and depilated
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skin samples tested, where Miif-m expression 1s demonstrated, Pax3c
expression is seen as well (1 8/19 samples). However, in the E1 2.5 embryo

Miif-m expression is not detected while Pax3c expression is. In the least, this
result indicates that while Miif-m expression may be reliant on Pax3c to initiate
expression, Pax3c expression is not solely required for maintenance of Miif-m
expression. Finally, no apparent correlation is evident between Miif-m and

Pax3d expression in our experiments as both inverse and overlapping
expression is randomly seen in embryogenesis and early anagen hair re
growth. While a double dosage effect due to concurrent PAX3C and PAX3D
expression such as is seen in CMM mqy effect MITF-M upregulation, these
results allow us to conclude that aberrant PAX3D expression does not solely

contribute to the progression of CMM through transactivation of MITF-M
6.5 PAX1 Expression in CMM
The hypotheses that aberrant PAX3 expression is linked to disruption
of normal c-l(jt or Miif-m expression in CMM are null; however, our study has
clarified significant aspects of PAX3/ Pax3 expression in normal melanocytic
cells therefore providing a greater framework for investigations of the role of

PAX3 in the tumouricity of melanocytes seen in CMM. To begin with, the
PAX3/Pax3 gene is known to play a role in the early morphogenesis of the
embryo being informally referred to as a "developmental control gene"; it is
currently thought that terminal cellular differentiation follows downregulation
of the PAX3 /Pax3 gene. Our study has supported this notion as we saw Pax3
mRNA expression in murine skin ceasing at embryonic day 20. Therefore, the
re-expression of this developmental control gene in metastatic CMM biopsies,
primary CMM tumours and melanoma cell lines (page 7 4, Scholl et al; 1999;
Barr et al; 1999) may be theorised as a consequence of three cellular
circumstances.
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Firstly, re-expression of PAXJ in CMM may be a consequence of
aberrant transcriptional regulation by its upstream genes. A known regulator
of PAXJ transcription, N-Myc is found expressed in CMM (Harris et al.,
2002; Bauer et al., 1990; Shin et al., 1987). Another PAXJ regulator, Tead2, is
not found expressed in CMM (Milewski et al., 2004), therefore, future
experiments are required to examine correlations between N-Myc and PAXJ
in CMM to determine whether PAXJ upregulation is a consequence of
upstream gene targeting.
Secondly, PAXJ re-expression may be a consequence of the neoplastic
melanocyte, once perturbed by a mutagenic event, undergoing a series of de
differentiation steps, taking it back to a stem cell state. Indeed, Mark Keating
and his colleagues at Harvard Medical School in Boston, Massachusetts, have
previously described a way to induce the de-differentiation of cells through
genetic manipulation (Odelburg et al., 2000). Many CMM pathologists theorise
that de-differentiation occurs within one or several melanocytes located in a
nest of atypical naevi which ultimately results in malignancy. This being the
case, however, it would seem that the probability of finding some PAXJ
expression within benign biopsies would exist (and in fact increase with an
increase in naevi numbers) as random naevi cells progressively de-differentiate
through devlopmntal stages and re-express PAXJ. However, Scholl et al
(1999) saw PAXJ expression strictly limited to cancerous melanocytes; they
saw no PAXJ expression in normal perilesional skin or benign naevi samples.
This leads to the possibility that a third oncogenic event causes the re
expression of PAXJ in CMM . In our depilation experiments, Pax] re
expression in adult murine skin is seen with the induction of anagen hair
regrowth

(almost certainly) related to proliferation or migration

of

melanoblasts or quiescent melanocytic precursor cells as they repopulate hair
follicles. If induced melanocytic apoptosis, such as is seen with excessive UV
exposure, leads to cell replacement from a stem cell population, perhaps
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subsequent mutagenesis of mitotic or post-mitotic replacement cells occurs in
CMM resulting in cell "suspension" at a stage in which PAX3 expression is
typical.
In any case, several significant points have been raised that require
further investigation. For example, is the clinical finding of PAX3 mRNA
expression in skin (the PAX3D isoform in particular) valid as a tumour
marker for CMM malignancy ? Does the expression of PAX3 occur in
serological studies of CMM patients and if so, does this clinically indicate
CMM metastates? Finally, if PAX3 expression tightly correlates with the
undifferentiated melanoblast cell state as we saw in our study, would
inactivation of the gene be sufficient to induce sustained regression of CMM
due to ensuing differentiation of tumour cells into melanocytes?
In conclusion, future studies of the CMM phenotype would benefit
from continued investigation of gene expression patterns, particularly those
involved in cell proliferation and migration (such as PAX3) during embryonal
patterning and development. As we continue to uncover the cellular events
that take place during the transformation of the undifferentiated stem cell to
the terminally differentiated adult cell, we may discover key players
responsible for the propagation of neoplastic cell properties.
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